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Venous thromboembolism (VTE) is a common disease with a myriad of presentation. It is 
often difficult to diagnosis with symptoms which are shared with many other disorders. 
Because of the overlap in symptomatology with other pathologies it is both commonly 
overlooked when present and commonly considered when absent. The threshold for 
investigating suspected VTE has dropped over time, in part due to a greater awareness of 
the disease among clinicians, but also because of the greater availability of diagnostic 
tests which are both accurate at positively diagnosing VTE and are patient friendly. This 
has resulted in a mushrooming of the number of diagnostic tests being performed for 
suspected VTE in radiology departments. As such radiology provides a window into the 
disease in a way that no other speciality can. All branches of medicine having their share 
of VTE patients but radiology provides a unique opportunity to study VTE patients as, no 
matter from which speciality they arise when the disease is suspected, they will almost 
inevitably end up undergoing a definitive radiological test.  There is much still to learn 
about VTE however developments in modern imaging and computerised databases have  
advanced our understanding of this common disease. The window that radiology provides 
into VTE has contributed towards those advances. 
  





Historical background of the thesis. 
 
When I started as a consultant radiologist the isotope lung scan (ILS) was the imaging 
method of choice for investigating suspected pulmonary embolism (PE) and contrast 
venography the principle investigation for suspected deep vein thrombosis (DVT). The 
main drawback with the ILS is that it uses indirect imaging to detect perfusion 
abnormalities, for which there are numerous causes, resulting in many diagnostically 
indeterminate studies.
1
 I first developed an interest in VTE in the early 1990s and the first 
paper which I published on venous thromboembolism addressed the thorny issue of how 
to managed indeterminate ILS.
2
 Imaging for suspected VTE has evolved dramatically 
over the past two decades. Doppler ultrasound scanning (US), which does not use 
ionising radiation, and which is quick, easy and patient friendly has now replaced contrast 
venography for the diagnosis of DVT, and more importantly CT  Pulmonary 
Angiography (CTPA) has replaced the ILS. This single factors more than anything else 
has revolutionized the diagnosis and understanding of venous thromboembolism. A factor 
made possible by the advent of helical or volume CT scanning and enhanced by the 
development in recent years of multi-slice CT scanning. Replacing indirect imaging, with 
all its inherent uncertainties, with direct imaging, enables confirmation or exclusion of PE 
with much greater certainty and permits more accurate quantification of thrombus load. It 
also allows detection of PE in situations where it hasn’t been clinically suspected. The 




papers which comprise this thesis span this period of cosmic change in VTE diagnosis. 
Access to a test with a high specificity which enables quantification has opened the door 




Understanding of VTE has improved over recent years and better diagnosis using modern 
imaging modalities has been the foundation for much of the progress that has been made. 
Diagnosis of VTE and standards of care for VTE patients are increasingly evidence based 
but there is still much to learn.  Not all cases of VTE are the same and there are many 
questions about the optimal type of treatment and optimum length of treatment for 
patients diagnosed with VTE still to be answered.  With increasing numbers of cases 
being diagnosed the pattern of disease has changed and maxims, previously laid down, do 
not necessarily still apply. Much of the evidence on outcome and treatment is based on 
historical data where many of the PEs identified were large.  With the lowering of 
thresholds for investigation many more smaller isolated segmental and sub-segmental PEs 
are  being found and it may turn out  that these do not need such prolonged treatment or 
indeed may not need treatment at all. This may be  particularly true for the smaller PEs 
that are detected ‘incidentally’ during contrast enhanced scans for other indications as 
demonstrated in chapters VII and VIII. The significance of below knee DVTs is still 
unclear. These are detected less frequently now that we have moved from contrast 




venography to Doppler ultrasound and there is a school of thought that smaller isolated 
below knee DVTs do not need treated.  When we published the paper in Chapter X of this 
thesis on the distribution of DVT as demonstrated by contrast venography the reviewers 
suggested that we look at the long term outcome of these patients to cast more light on the 
significance of below knee DVT, and the need or otherwise for active treatment, 
particularly to look at the risk of recurrent DVT and of the risk of venous insufficiency 
syndrome in this cohort.  We took this advice and have shown a significant incidence of 
both conditions in our isolated below knee DVT cohort over time, work which is under 
preparation for publication. Another area of current uncertainly is how to manage the 
pregnant patient with suspected PE. Our present protocol uses a combination of isotope 
lung scan and CTPA with triage depending on CXR findings with this scheme based on 
radiation dose to mother and child. This is a field where the evidence base is limited and 
which is likely to be impacted by advances in Magnetic Resonance pulmonary 
angiography where ionising radiation is avoided and which I am sure will play an 
increasing part in the imaging of suspected PE. MR Pulmonary angiography is not the 
only cross-sectional imaging advance. There is now the opportunity for 4D imaging of 
patients who have suffered a PE with both Volumetric CT and MRI imaging. This allows 
assessment of residual thrombus load and evaluation of perfusion abnormalities which 
occur and persist due to micro-vascular occlusion even when there is no morphological 
imaging evidence of residual thrombus. This has the potential advantage of identifying 
patients at longer term risk of developing pulmonary hypertension at an earlier stage 




permitting tailoring of therapy and earlier therapeutic intervention. This is a field which 
we are currently actively exploring having attracted a pilot grant and for which we are 
seeking further funding. 
There are many questions still to be answered about VTE. The papers included in this 
thesis have cast light upon some of the questions that exist but it is hoped that, in 
collaboration with academic and thoracic clinical colleagues, to further advance the 
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Purpose: To assess the change in practice and resulting diagnostic outcome in the 
radiological investigation of pulmonary embolism since the introduction of helical 
CTPA in a large teaching hospital. 
Methods and Materials: A retrospective review was undertaken of all radiological 
investigations performed over a 6-year period before and after the introduction of 
CTPA (protocols 1 and 2, respectively) as an integral part of the imaging protocol in the 
investigation of clinically suspected PE. The total numbers and results of all 
investigations are assessed for each protocol.  
Results: A substantive increase in both the total number of patients and the number of 
investigations performed for the investigation of PE since the introduction of CTPA 
occurred. Five hundred and twenty-six patients underwent 617 investigations performed 
in 1995/1996 with 760 patients undergoing 805 in 2001/2002. There was a significant 
decrease in the number of investigations per patient, 1.17 in 1995/1996 versus 1.06 in 
2001/2002. Primary investigation showed a significant decrease in indeterminate 
examinations from 25.7% to 8.5% and an increase in positive results for pulmonary 
embolism from 18% to 24%.  
Conclusion: In the study population there was a significant increase in the number of 
patients being investigated for PE, with a decrease in both the number of non-diagnostic 
investigations and the total investigations per patient since the introduction of helical 
CTPA. This is probably due to the ready availability of a new imaging technique and 




physicians awareness, that CTPA has significantly improved specificity, which 
encourages the referral of patients for investigation.  
Introduction   
 
Pulmonary thromboembolism (PE) is a common condition with significant morbidity 
and mortality; the latter reaching 30% in some series in untreated cases 
(1,2)
. Appropriate 
use of anticoagulation or thrombolytic therapy improves outcome with a reduction in 
mortality to as little as 2.5 %
(3)
. Therapy however is not risk free and serious 
complications may occur 
(4)
. Identifying the correct patients to treat is therefore 
essential. Unfortunately the clinical manifestations of PE are variable and lack 
specificity to reliably diagnose or exclude clinically significant PE 
(5)
. Imaging is 
mandatory to confirm the diagnosis but there is no general agreement on the best 
strategies.  
Although chest radiographs are non-specific for PE they are essential in the 
interpretation of lung scintigrams and may allow an alternative diagnosis that may 
account for the clinical presentation 
(6,7)
. Lung scintigraphy is a safe and sensitive 
investigation for suspected acute PE 
(8)
. The main drawback with this technique is the 
high proportion of indeterminate examinations requiring further investigations 
(8,9)
. 
Pulmonary angiography has been considered the gold standard in the investigation of 
PE but is usually reserved for those cases deemed indeterminate by first line non-
invasive tests. It is an invasive investigation, is not universally available and has a small 




but recognised morbidity and mortality 
(8)
. This may account for its low utilisation; less 
than 2% in some studies 
(10,11)
. Helical computed tomographic pulmonary angiogaphy 
(CTPA) and the newer multi-slice CTPA have changed the investigation of PE.  
Multiple studies have reviewed CTPA against both formal pulmonary angiography and 
ventilation/perfusion nuclear imaging( V/Q) and have consistently demonstrated a high 
sensitivity and specificity 
(12-17, 20)
 with good inter-observer agreement 
(18)
. It is only 
minimally invasive and allows direct visualization of the thrombus and thrombus load. 
Single slice helical CTPA is largely limited to demonstrating PE to segmental artery 
level at present whereas multi-slice CTPA can show subsegmental PE. Whether 
subsegmental emboli contribute significantly to morbidity and mortality is debatable 
(19)
. Multi-slice CTPA can visualize subsegmental PE, is minimally invasive, and is 
replacing conventional pulmonary angiogram as the gold standard 
(24)
.    
 Previous studies have reviewed different protocols for the investigation of PE 
with a combination of CTPA and lung scintigrams 
(21,23)
. Within our centre we use a 
combined protocol incorporating both perfusion (Q) lung imaging and CTPA. The 
purpose of the present study was to assess the change in practice and resulting 
diagnostic outcome in the radiological investigation of pulmonary embolism since the 
introduction of CTPA.    
 




Materials and Method 
A retrospective review was carried out of all radiological investigations performed in 
patients with clinically suspected PE. In total six years were reviewed, commencing one 
year prior to the introduction of CTPA as an integral part of the imaging protocol in the 
investigation of PE, thereby allowing assessment of two protocols (Fig 1&2). Protocol 1 
was employed before the introduction of CTPA and protocol 2 after it was introduced 
into the diagnostic algorithm. The total number and results of all investigations in both 
protocols were reviewed for the first and last years.  Local population served remained 
unchanged throughout the study.    
 Lung scintigrams were obtained using a GE MaxiCamera 400 (Single Head) 
Gamma camera. 80MBq technetium-99m macroaggegated albumin (MAA) was 
injected via a peripheral intravenous cannula with saline flush. Images were acquired in 
anterior, posterior, right and left anterior and posterior oblique projections, with 
400,000 counts per image. Those patients requiring ventilation as part of this study 
(protocol 1) received 160MBq of Xenon133 via aerosol. Reports were divided into 
three groups, normal, indeterminate and high probability with the first and last as 
described in PIOPED 
(8)
 and all other findings grouped as indeterminate. CTPA was 
performed on a GE HiSpeed Advance CT (Milwaukee, WI, USA). 
100 millilitres of non-ionic contrast media (Niopam 300mg/ml), diluted with 40mls of 
saline, was injected via a 16 or 18G needle in the antecubital fossa at a rate of 4mls/sec. 




Images were obtained with a delay of between 10 and15 seconds, depending on the 
patients cardiac status, from diaphragm to aortic arch (pitch of 1.7, 3mm slice thickness 
with image reconstruction at 1.5mm intervals). Venography and Doppler examinations 
are well recognized investigations for deep venous thrombotic disease and were 
performed using standard protocols. Conventional pulmonary angiography was 
performed using a femoral approach and 100cm 5F pigtail catheter. Selective right and 
left main pulmonary artery runs with AP and 30
0
 anterior oblique views were 
performed. Coned segmental runs were acquired when indicated. 
 
Results 
In the first year 526 patients were investigated for PE, using protocol 1, with 617 
examinations performed, equivalent to 1.17 per patient. All patients had chest 
radiographs as part of their investigation in both protocols. These have not been 
included in the assessment of the number of investigations each patient underwent.  
Five hundred and twenty six lung scintigrams studies demonstrated a combined positive 
or normal result in 74% with the remaining 26% being indeterminate. Additional 
investigations were performed in 63% in the latter group or 17% of the total number of 
patients (Table 1). Pulmonary angiography was performed in only 7.4% of 
indeterminate cases and is in line with other studies
(10,11)
. In 9% of second line 
investigations results were not available for the study.  




In the final year of the study 760 patients were investigated for clinically suspected PE, 
using protocol 2, with 805 investigations, equivalent to 1.06 per patient. This is a 44.5% 
increase in the total number of patients being investigated. CTPA was the primary 
investigation in 59% of patients and was diagnostic, i.e. positive or negative for PE in 
97.6%. Q was performed in the remaining 41%. This examination was diagnostic in 
80% with 21% indeterminate.  Further investigations included CTPA in 48% of the 
indeterminate group from the perfusion arm with 26% of these secondary investigations 
being positive (Table 2). 
All statistical analysis was performed comparing proportions using Chi-square with 
SAS/STAT version 8.2 (SAS Institute, Cary, NC, USA). Forty-four percent more 
patients were investigated for PE in the year 2001/2002 with protocol 2 versus the year 
1995/1996 with protocol 1, p<0.001.  Our hypothesis is that with the advent of CPTA 
more physicians were referring their patients for diagnostic tests. 
When comparing patients being investigated with protocol 2 vs protocol 1, patients in 
protocol 2 had a statistically significant higher initial diagnostic test (either positive or 
negative) 90% versus 74 % in protocol one (p<0.0001).  This result supports our finding 
that patients being investigated under protocol 2 had overall less diagnostic tests 
performed 1.06 compared to 1.17 tests per patient with protocol 1. 
Total CTPA and lung scintigram, combined ventilation/perfusion and sole ventilation, 
examinations were reviewed over the six-year period, 1995-2002 (fig 3). This 
demonstrates a 51% increase in the total number of investigations during this time. 




From its first year of introduction CTPA has increased rapidly with significant more 
CPTAs performed now than lung scintigrams. Lung perfusion examinations have 
decreased but at a slower rate than the increase in CTPA, reflecting the significant rise 
in patients being investigated.  
The first year of the study had a male/female ratio of 48/52% with a mean age of 
51.8/52.5 years respectively with the same age range (17-98). The final year had a 



















































Figure 1 Protocol 1 
 
















































Figure 2 Protocol 2 
 
 




                   
 
Figure 3 Comparison of CTPA/CPA and lung scintigrams 
 
Discussion 
The current debate in the diagnostic imaging of pulmonary embolism focuses on 
whether CTPA should be a primary or secondary investigation. In the majority of 
hospitals it is established as an integral part of the algorithm for investigation suspected 
pulmonary embolus although its role varies from institution to institution. Our current 
protocol incorporates its use depending on both the clinical presentation and chest 
radiograph findings. This may change with the introduction of multi-slice CT as the 
increased sensitivity of CTPA is likely to result in even greater utilization of CTPA as a 
primary investigative tool.  




All diagnostic imaging tests for PE have their limitations. CXR demonstrate 
abnormalities in the vast majority of patients with clinically suspected PE regardless of 
the final diagnosis. Chest radiographs are normal in 12 and 18% of patients with and 
without PE respectively in those patients who are clinically suspected to have PE and 
have a negative predictive value of 74%
(8)
. They do however present alternative 
diagnoses, a baseline from which to follow the patient radiologically, and in our 
institution a simple method to assess which arm of the protocol a patient enters 
(19)
. In 
this study, after the introduction of CTPA, patients who had a normal CXR without a 
history of chronic lung disease received a perfusion scan (protocol 2), the remaining 
patients were allocated to CTPA. The ventilation scintigraphy was not performed in the 
former group as it provides no significant change in sensitivity and specificity 
(9,13,22)
.  











Positive  18% 40% 28 % 41% 
Normal 56.3% 60% 59% 59% 
Indeterminate 25.6% 0% 13%Result 
Unavailable 
0% 
Total 100%(526) 100% (10) 100% (64) 100%(17) 
 
Numbers of patients given in parenthesis. venography, conventional pulmonary  
angiography, lower limb Doppler imaging 
 
The percentage of patients referred for lung scintigraphy changed dramatically in 
protocol 2 with the majority of patients (59.3%), allocated to CTPA. Decreases in the 




indeterminate results in scintigraphy occurred, 25.6% and 20.7% in protocol 1 & 2 
respectively, which can be accounted by the exclusion of patients with an abnormal 
CXR and/or chronic lung disease who are more likely to have a non-diagnostic lung 
scan
(19)
. In addition however there was a significant drop in the total number of 
indeterminate investigations from 25.6% to 9.9%. The corresponding increase in 
diagnostic outcome rose from 74.3% to 90.1% of first line radiological investigations. 
Second line investigations decreased from 17.3% in protocol 1 to 5.9% in protocol 2 in 
line with the dramatic decrease in indeterminate results. 
 Comparison with previous studies was not directly possible because, on review of the 
relevant literature on Medline, no study incorporated our second diagnostic protocol.  
Our first protocol however can be compared. The number of positive scintigraphic 
studies is compatible with previous studies 
(8,9,21)
, but there is a notable increase in the 
number of negative studies that is present in both protocol arms. This finding may be 















Perfusion nuclear imaging 
Positive 30% 15% 
Normal 68% 64% 
Indeterminate 2% 21% 
Total 100% (451) 100% (309) 
 












Pos 0 43% 67% 26% 0 
Neg 100% 57% 33% 74% 100% 
Indet 0 0 0 0 0 
Total 100%(1) 100% (7) 100%(6) 100%(31) 100%(1) 
 
Numbers patients given in parenthesis. CTPA, pulmonary angiography, venography, 
conventional lower limb venography, lower limb venous Doppler imaging, Q, perfusion 
nuclear imaging  
 
The expected increase in referrals with the introduction of a new imaging technique, 
CTPA, took place with a year on year rise for the first four years with a temporary 
plateau in the latter two years. Review of the most recent figures (April 2003) has 
demonstrated a further significant rise in utilization of CTPA to 707 for the twelve 
months since the end of the study. This rise is likely due to greater access to our CT 
scanner and a lower clinical threshold. The corresponding drop in perfusion 
examinations, 41%, showed a slower decline in the last year, 299 in the most recent 
figures, but may continue to decrease further with longer term follow-up.  




 The steadily increasing demand for CTPA within our institution needs to be addressed. 
Recently published British Thoracic Society guidelines for the management of 
suspected PE stresses the importance of clinical probability assessment in the initial 
patient review and highlights the role of D-dimer testing 
(25)
. We intend to adopt these 
guidelines in a locally tailored version and commence D-dimer testing. Lung 
scintigraphy, in those with a normal CXR, remains an integral part of our protocol and 
thus reduces the demand that would be placed on CTPA if the latter were the sole 
primary imaging investigation. 
In conclusion our results demonstrate a significant increase in the number of patients 
being investigated for pulmonary embolism in our institution with a decrease in the 
number of non-diagnostic investigations since the introduction of helical CTPA. This 
may be due to a combination of factors. The introduction of a new imaging technique 
has focused both physicians and radiologists on a potentially lethal and relatively 
common condition. This increased awareness, combined with the knowledge that CTPA 
has a significantly improved specificity, encourages physicians to refer patients for 
investigation. The introduction of CTPA and a new investigative protocol has produced 
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To assess the change in patient radiation dose in the radiological investigation of 
pulmonary embolism since the introduction of helical Computed Tomography Pulmonary 
Angiogram (CTPA) in a large teaching hospital.  
 
Methods and Materials: 
 All radiological investigations performed as an integral part of the imaging protocol in 
the investigation of clinically suspected pulmonary embolism (PE) over a six year period 
before and after the introduction of CTPA were retrospectively reviewed. The protocol 
for investigation of PE changed in our institution after the introduction of CTPA. 
Protocols 1 and 2 were protocols in place before and after the introduction of CTPA, 
respectively. An In-depth evaluation was made of the imaging records and radiation dose 
for 30 consecutive patients investigated for clinically suspected PE in 1995 (protocol 1) 
and 2002 (protocol 2). Radiation doses were then extrapolated for the total number of 
patients investigated in each year. 
 
Results:  
The number of radiological investigations performed per patient decreased from a mean 
of 1.17 in protocol 1 to 1.06 in protocol 2. There was a 44% increase in the total number 




of patients investigated. The effective dose per patient increased from 1.30mSv to 
1.35mSv with the introduction of CTPA into the imaging protocol, an increase of only 
4%. First line investigations showed a significant decrease in indeterminate examinations 
from 25.7% to 8.5%.  
 
Conclusion:  
Two different imaging protocols are reviewed with respect to type and number of 
procedures required for the investigation of PE and the resulting patient effective dose 
incurred. Results demonstrate an increase in the number of patients being investigated for 
suspected PE and a small increase in effective dose per patient since the introduction of 
helical CTPA. Although CTPA in itself incurs a higher effective dose, this is offset by the 
significant decrease in the number of non-diagnostic and total number of investigations 
per patient. We hope that this paper will serve as a stimulus for the radiological 
community to examine current protocols in all areas of diagnostic imaging. We stress the 
importance of assessing new and established imaging protocols to maximise the benefit 
and reduce the risk to patients. 
 
 Introduction 
The introduction of a new diagnostic imaging test in the investigative protocol for the 
diagnosis and management of patient pathology requires the fulfilment of several criteria. 
The predominant criteria is that the benefit of the test outweigh any incurred risks and 




that this benefit/risk ratio is equal to or greater than the imaging tests already in place. In 
the investigation of pulmonary embolism (PE) helical computed tomographic pulmonary 
angiogaphy (CTPA) and the newer multi-slice CTPA require both the use of ionising 
radiation and intravenous contrast material (IVCM) which can be considered risk factors. 
The risk of adverse reactions from IVCM is established but to our knowledge there has 
been no review of the radiation dose incurred in this new investigation as part of a 
diagnostic imaging protocol with direct comparison to those imaging tests previously 
available. The purpose of our study is to assess what impact the introduction of helical 
CTPA in the investigation protocol of pulmonary embolism has had on patient radiation 
dose. In addition we review the measurement of this radiation dose and the significance 
of this to the patient. 
 Pulmonary embolism is a common condition with significant morbidity and mortality, 
the latter reaching 30% in some series in untreated cases.
(1,2)
 Appropriate use of 
anticoagulation or thrombolytic therapy improves outcome with a reduction in mortality 
to as little as 2.5%.
 (3)
 Therapy however is not risk free and serious complications may 
occur. 
(4)
 Identifying the correct patients to treat is therefore essential. Unfortunately the 
clinical manifestations of PE are variable and lack specificity to reliably diagnose or 
exclude clinically significant PE. 
(5)
 Imaging is mandatory to confirm the diagnosis but 
conventional strategies have been imprecise. 
(6)
  
Multiple studies have reviewed CTPA against both formal pulmonary angiography and 
radionuclide ventilation/ perfusion (V/Q) imaging and have consistently demonstrated a 




high sensitivity and specificity.
(7-12)
 It is only minimally invasive, allows direct 
visualization of the thrombus and thrombus load. However demonstration of PE in 
vessels beyond segmental artery level is limited at present for single slice CT. Whether 
sub-segmental emboli contribute significantly to morbidity and mortality is debatable. 
(13)
  
The dosimetric measurement that provides a direct relationship to the radiation hazard is 
the effective dose (ED). This was introduced in 1990 by the International Commission on 
radiation protection and is defined by the sum of the products of the equivalent organ 
dose and its relevant organ weighting factor for all tissues and organs within the body. It 
is therefore not measured directly. Expressing the dose in the form of an effective dose 
allows the relative biological effect and therefore the relative risk of different radiation 
doses to be compared directly. It is the most appropriate measurement for use in this 
study due to the use of different imaging modalities which employ different types of 
radiation 
 Materials and Method  
A retrospective review of imaging protocols for the investigation of PE pre and post the 
introduction of CTPA was performed. Protocol 1 and 2 were assigned to the imaging 
protocols in place in our centre before and after the introduction of CTPA, respectively 
(figures 1 and 2). Imaging records and radiation dose for 30 consecutive patients 
investigated for clinically suspected PE in 1995 were reviewed. Plain radiographs were a 
necessary part of both protocols and therefore were excluded from further calculations 
assessing the change, if any, in effective dose. Radionuclide lung scintigrams (V/Q) and 




where appropriate lower limb venography and conventional pulmonary angiograms were 
assessed. The process was repeated in 2002 using the same parameters with the addition 
of CTPA. Due to the small number of conventional pulmonary angiograms, each of these 
studies was separately assessed for ED. The same applies to the seven cases of lower limb 
venography in protocol 2, with 20 cases assessed for protocol 1. Both years were then 
assessed with respect to the total number of radiological investigations performed for 
clinically suspected PE and the total effective doses involved. Patients in protocol 2 had a 
perfusion scan performed if the chest radiograph was normal and there was no history of 
chronic pulmonary disease. If the chest radiograph provided an alternative diagnosis, no 
further imaging was performed with respect to PE unless there was a high clinical 
suspicion of concurrent PE. Otherwise the remaining patients proceeded to CTPA. 
Radio-nuclide lung scintigrams were obtained using a GE Maxi Camera 400 (Single 
Head) Gamma camera. 80MBq technetium-99m macro-aggregated albumin (MAA) was 
injected via a peripheral intravenous cannula with saline flush. Images were obtained in 
anterior, posterior, right and left anterior and posterior oblique, with 400,000 counts per 
image. Those patients requiring ventilation as part of this study, protocol1, received 
160MBq of xenon-133 via aerosol. Reports were divided into three groups, normal, 
indeterminate and high probability and assessed in conjunction with the clinical 
presentation. 
 


























Fig 1-Protocol 1 radiological investigation clinically suspected 
pulmonary embolism (PE) pre CT pulmonary angiography (CTPA). 
CXR, chest radiograph; U/S, ultrasound.  






Fig 2-Protocol 2 Radiological investigation of clinically suspected 
Pulmonary embolism post introduction of CT pulmonary angiography 


































CTPA was performed on a GE HiSpeed Advance CT machine (Milwaukee, WI, USA). 
100 MLS non-ionic contrast media (Niopam 300mg/ml) diluted with 40mls of saline was 
injected via a 16 or 18G needle in the ante-cubital fossa at a rate of 4mls/sec. Images were 
obtained with a delay of between 10-15 seconds, depending on the patients cardiac status, 
from diaphragm to aortic arch using a pitch of 1.7, 3mm slice thickness with image 
reconstruction at 1.5mm intervals. kVp, mA and the number of slices per examination 
were noted.  
Venography and Doppler examinations are well recognized investigations for deep 
venous thromboembolic disease and were performed using standard protocols. 
Conventional pulmonary angiography was performed using a femoral approach and 
100cm 5F pigtail catheter. Selective right and left main pulmonary artery runs with AP 
and 30
0
 anterior oblique views were performed. Coned segmental runs were acquired 
when indicated 
Patient Dosimetry.  
Doses for CT scanning were calculated from the CT dose index measured in air (CTDIair) 
using the matched scanner technique developed by ImPACT 
(14)
. Patient organ and 
effective doses from CT examinations use the NRPB Monte Carlo dose data for CT 
scanners 
(18)
. Doses for the radionuclide studies were derived from activity using ARSAC 
Notes for Guidance 
(15)
. 




For conventional pulmonary angiography and for venography,, effective dose was 
calculated from dose-area product (DAP) using conversion factors taken from Hart et al 
(16)
.  All dose calculations assume that the patients have an average build. 
 










Venography Doppler US 
Positive 95(18) 4(40) 18(28) 7(41) 
Normal 296(56.3) 6(60) 38(59) 10(59) 




Total 526 10 64 17 
    
  
Results    
The dose for CTPA was calculated for 16 patients. The average ED was 1.6mSv The 
standard scanning protocol was used for all patients with the only variant being the 
scanned length varying from 78mm to 108 mm leading to a relatively small range of ED 
(1.4-1.9 mSv). V/Q (protocol 1) and Q (protocol 2) imaging were associated with doses 
of 1.2 mSv and 0.8 mSv, respectively, with no variation since the same activity was used 
for all patients. Doses for lower limb and pelvic venography were assessed for 12 
patients. For these patients the average DAP was 3.1 Gy cm
2
 (range 1.7 to 7.2) from 
which it was estimated that the average ED was 0.3 mSv. Doses for conventional 
pulmonary angiography were assessed for three patients. The average DAP was 21.3 Gy 
cm2 from which ED equal to 3.2 mSv was calculated (range 2.3 to 4.1 mSv). 





Both years were then reviewed with respect to total investigations and results. In the first 
year 526 patients were investigated for PE with 617 examinations performed, equivalent 
to 1.17 per patient. 526 V/Q studies demonstrated a combined positive or normal result in 
74.3% with the remaining 25.7% been indeterminate. Additional investigations in the 
latter group were performed in 63% (Table 1). The average effective dose was 1.30 per 
patient  with 92% of this average being attributed to the V/Q studies. (Table 2).  
 
 
Table 2: Effective dose (mSv) per Examination Protocol 1 
 
Investigation ED Patient No Total ED 
V/Q 1.2 526 631.2 
Pul Angio 3.2 10 32 
Venography 0.3 64 19.2 
Doppler Ultrasound 0.0 17 0.0 
 
Mean ED per patient = 1.30mSv 
 
In the final year of the study 760 patients were investigated for clinically suspected PE, 
with 805 investigations, equivalent to 1.06 investigations per patient. CTPA was 
diagnostic in 97.8%, been the primary investigation in 59.3% of patients with Q lung 
scanning in the remaining 40.7%. The latter examination was diagnostic in 79.3% with 
21% indeterminate. Further investigations included CTPA in 48% of the indeterminate 
group with 26% been positive (Table 3). 
 




Table 3 (a and b) Results Protocol 2, %=() 
 
a) Primary investigation 
 










Total 451 309 
 




2.2% of CTPA examinations were indeterminate. In 8.9% of patients in the second 
protocol further investigations were performed due to discrepancy between the clinical 
and radiological diagnosis and to assess the presence and extent of peripheral thrombus.  
The average effective dose was 1.35mSv per patient with 24% and 75% of this being 








Venogram Doppler CTPA 
(Q 
Indeterminate) 
Q (CTPA  
Indeterminate) 
Positive 0 3 4 8(26) 0 
Normal 1 4 2 23(74) 1 
Indeterminate 0 0 0 0 0 
Total 1 7 6 31 1 




Table 4: Effective dose (mSv) per Examination Protocol 2 
 
Investigation 
ED Patient No Total ED 
Q 0.8 309 247.2 
Pul Angio 3.2 1 3.2 
Venography 0.3 7 2.1 
Doppler Ultrasound 0.0 6 0.0 
CTPA (Total) 1.6 482 772.8 
 
Mean ED per patient = 1.35mSv 
 
Discussion 
Radiological examinations are required to conform to two principles: justification to 
ensure that the benefit outweighs the risk, and optimization to ensure that dose is kept as 
low as reasonably achievable (ALARA) consistent with the clinical imperative for 
accurate diagnosis.  In radiology using ionising radiations, risk is assumed to be 
proportional to effective dose. In evaluating any new investigation protocol, it is not only 
necessary to consider the benefits in terms of diagnostic accuracy and patient 
acceptability, the risks, including the radiation risks, must also be assessed. Radiation 
risks are assessed in terms of affective dose and for the general population, the fatal 
cancer risk has been estimated to be 5% per sievert 
(17)
.  In this study we have considered 
the radiation risks for two protocols. In protocol 1 all patients for whom PE was not 
excluded by a preliminary chest X-ray had V/Q scans with an average of 0.16 additional 
follow up radiology investigations, the average patient dose was 1.3mSv.  More recently 




(in protocol 2) the chest X-ray has been used to determine whether a perfusion scan or a 
CT pulmonary angiogram is the most appropriate investigation. For this protocol the 
number of follow up radiological investigations was reduced (to an average of 0.07 per 
patient) and the average effective dose per patient (1.35 mSv) was not significantly 
different. The overall radiological risk for the two protocols is therefore in the range of 6 
to 7 fatal cancers per 100 000.  
There are significant uncertainties in the estimation of effective dose from the measurable 
dosimetry quantities, i.e. activity, DAP and CTDI. In each case the standard conversion 
factors from the measured quantity to ED are taken from calculations based on a 
mathematical phantom representing an average sized person. The inherent uncertainties in 
the calculation depend on whether it is an internal radiation source, as in radionuclide 
imaging, or whether it is an external source, CT or conventional angiography. There are 
additional uncertainties introduced into the CT dose calculation due to the use of the 
scanner matching method used in the ImPACT dose calculator 
(14)
. There are also patient-
to-patient dose variations, the effect of which may have influenced the results of the study 
due to the relatively low proportion of the full patient cohort for whom doses were 
assessed. However, the effect of these variations was minimized by standardization of the 
three principle investigations. In protocol 1, 92% of the average patient dose was from the 
V/Q scan for which a standard activity was administered. In protocol 2, 24% of the dose 
was from perfusion scans with a standard activity and 75% of the dose from CTPA in 
which the maximum to minimum dose ratio assessed for 16 patients was 1.36.  The much 




bigger uncertainties in the dose for the other examinations (venography and conventional 
angiography) therefore have little significance in the overall conclusions. 
The results are for a particular model of a single slice helical scanner used for CTPA in 
this Hospital at the time of this study.  The variation in dose between different models of 
scanners and between different institutes is known to be very large, e.g. by a factor of 8.4 
for routine chest CT in an early CT dose survey 
(19)
. It should also be noted that it is 
increasingly common to use mult-islice scanners for CTPA studies for which the dose 
might be expected to be higher than reported here due to the use of a lower effective 
pitch. Notwithstanding these reservations regarding the dose which might be given 
elsewhere, it has been demonstrated that it is possible to use CTPA in protocol 2 without 
a significant increase in effective dose and thus in radiation risk. 
 The new diagnostic protocol that we present has a minimal increase in effective dose. 
The ED for CTPA is higher than perfusion or V/Q scans and the role and position CTPA 
in other diagnostic protocols must be carefully examined so the patient receives the 
optimum benefit while minimizing risk.  
In conclusion, our study has reviewed the total effective dose of the diagnostic imaging 
protocols as outlined above pre and post introduction of CTPA. Although in itself CTPA 
has a higher ED than the previously used V/Q imaging, the reduction in the number of 
additional investigations, and performing perfusion only for lung scitigraphy in protocol 
2, has limited its impact from an ED viewpoint. With the introduction of CTPA there has 




been a significant increase in the total number of patients investigated, which is likely due 
to a multitude of factors including increased awareness of a disease with the advent of a 
new diagnostic tool, , a reduction in the numbers of non-diagnostic results and the 
possibility of identifying alternative diagnosis. This has led to a corresponding increase in 
the total population radiation dose but only a minimal increase in the ED per patient 
investigated. This must be balanced against the social, economic and patient benefit due 
to the reduced number of examinations performed per patient and the significant 
reduction in the number of non-diagnostic examinations of a potentially fatal medical 
condition. The study will serve as a valuable baseline for the assessment of multi-slice CT 
with respect to ED. We hope this paper will serve as a stimulus for the radiology 
community to examine current protocols in all areas of diagnostic imaging. We stress the 
importance of assessing new and established imaging investigative protocols to maximize 
the benefit and reduce any risk to patients.  
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Relatively little is known about the prognosis of patients in whom clinically suspected 
pulmonary embolism (PE) is refuted by diagnostic imaging. 
Aim. 
 This prospective study of suspected PE therefore compared clinico-radiological features 
and outcome in patients with and without PE.  
Methods.  
Computed tomographic pulmonary angiography (CTPA) confirmed or refuted PE in 
consecutive patients. Clinical, laboratory and radiological features were recorded at 
baseline, and mortality at 1 year determined. Univariate and multivariate analyses 
identified variables associated with PE.  
Results.  
PE was diagnosed in 45 patients and refuted in 141. The PE and ‘non-PE’ groups were 
similar with regard to extravascular radiology (though consolidation was significantly 
more common in the PE group [present in 24 (53%) of the PE group and 42 (30%) of the 
non-PE group, P<0.01)], co-morbidities (no significant differences), and baseline 
characteristics (only serum D-dimer concentrations were independently associated with 
PE by multivariate analysis, P=0.001). Right ventricular dimensions were significantly 




higher in the PE group, [right ventricular to left ventricular ratio was 0.98 (range 0.64-
2.48) in the PE group and 0.92 (range 0.66-1.950 in the non-PE group, P < 0.05). In the 
PE group, right ventricular dimensions rose sharply when 10 or more segmental 
pulmonary arteries were occluded. One year all cause mortality was 6.7% in the PE group 
and 13.5% in the non-PE group (no significant difference P=0.218). 
Conclusion.  
Among a cohort of patients presenting with clinically suspected PE, clinical 
characteristics, co-morbidities and radiological features were similar when comparing 
groups with CTPA-proven or CTPA refuted PE. However RV dimensions, radiological 
consolidation on imaging and D-dimer levels were significantly higher in the PE group. 
Patients with suspected PE have a poor prognosis irrespective of whether PE is 
confirmed. This appears accentuated in patients without PE, a finding possibly under-
recognised in clinical practice.  
    
INTRODUCTION 
The annual incidence of PE has been estimated at up to 70 per 100,000 placing a massive 
strain on health resources 
1,2 
Acute pulmonary embolism (PE) has been estimated to cause 
over 50,000 deaths per annum in the United States.
,3
  
However the clinical diagnosis of acute PE remains notoriously difficult.
4 
Among patients 
with clinically suspected PE who proceed to diagnostic imaging, objective evidence for 
thrombus in the pulmonary arteries is typically found in around 20%. Clinical outcomes 




after PE have been carefully characterised in previous studies.
 5-12
 However less is known 
about the clinical features and outcomes of patients in whom diagnostic imaging refutes 
PE. By definition these patients present with clinical features mimicking PE. While this 
heterogeneous subgroup has been studied with respect to the risk of subsequent venous 
thromboembolism,
13-15
 few studies have characterised clinico-radiological features and 
all-cause mortality in detail.  
  
Figure 1. CTPA demonstrates pulmonary embolism and associated right 
ventricular dilatation. Black arrows demonstrate maximal end-diastolic 
dimensions of the right ventricle (RV) and left ventricle (LV), showing RV 
dilatation and septal (S) bowing. The white arrow demonstrates a segmental right 
lower lobe thrombus. 
 
With this in mind our primary aims were to establish whether patients presenting acutely 
with suspected PE have a worse outcome if PE is proven, and also whether co-morbidities 
or radiological changes in the lungs (assessed by CTPA) were differentially distributed in 
the PE and non-PE groups.  CTPA allows detection of pulmonary emboli to the level of 




sub-segmental arteries. CTPA also has the advantage of simultaneously assessing the lung 
parenchyma, the extent of thrombus in the pulmonary arterial tree, and cardiac 
dimensions.
16-19
 Secondary aims of this study were therefore a) to compare right 
ventricular dimensions in patients with and without PE, and b) to assess the relationship 
between right ventricular dilatation, thrombus load and outcome within the group of 
patients with confirmed PE. 
 
METHODS 
This was a prospective, observational, non-interventional cohort study performed in a 
single university teaching hospital over 4.5 months. Eligible patients were those 
presenting acutely to hospital in whom admitting physicians were sufficiently suspicious 
of acute PE to request a CTPA, completion of which triggered entry into the study.  
The route of entry to the study was designed to be pragmatic and to reflect ‘real life’, ie 
CTPA requests were not influenced by the study team and use of pre-test prediction 
models was entirely at the discretion of the referring physician. Patients who were already 
in-patients at the time PE was suspected were not included. CTPAs were performed using 
a multislice CT scanner (Aquilion 16, Toshiba Medical Systems Ltd) and 1mm 
collimation with images viewed on a Vitrea Workstation (Toshiba Report Direct V500). 
CTPAs were reported by the hospital’s diagnostic service. However all scans were 
independently reviewed by an experienced pulmonary radiologist (JTM).  
 




Table 1 Univariate analysis of clinical variables in PE and non-PE groups  
 
The first three variables are expressed as n(%). The lower nine variables are 
expressed as medians (ranges),and n denotes the number of patients for whom 
data were available- the study was designed to reflect actual clinical practice  (i.e. 
whether variables were measured/recorded was entirely at the discretion of the 
attending clinical team), hence n is often less than 45 in the PE group and less 
than 141 in the non-PE group. Values from the arterial blood samples (PaO2 and 
PaCO2 and H
+) and O2 saturation were only included in analysis if the sample or 
reading were taken with the patient breathing room air.  
In the right hand column *P<0.05,**P<0.001 when comparing the PE and non-PE 
groups. Absence of symbols denotes no statistically significant difference. 
 
The study design stipulated that discrepancies in opinion between the study radiologist 
and the diagnostic service would be discussed and the final diagnosis reached by 
consensus. The study design also stipulated that CTPAs deemed to be indeterminate for 
technical reasons were excluded from analysis. The study radiologist assessed cardiac 




dimensions in all patients, and quantified the degree of pulmonary arterial occlusion in 
patients with PE. Cardiac dimensions were assessed using axial images to determine the 
maximum diastolic dimension of the right and left ventricular (RV and LV) chambers, 
expressed as a ratio (RV:LV ratio) (Figure 1). Thrombus load was quantified according to 
criteria described by Miller, adjusted for CTPA by Bankier et al.
16,17
This generates a 
modified Miller score (MMS) of 0-16, whereby the segmental pulmonary arteries (nine 
on the right, seven on the left) are observed and a score of 1 is attributed to each artery 
occluded by thrombus. Any more proximal occlusion scores the number of segmental 
branches distal to the occlusion. 
 
Figure 2. Co-morbidities described in the PE and ‘non-PE’ groups. No 








Evidence of other cardiopulmonary diseases detectable at CTPA (eg consolidation, 
pleural effusions, emphysema etc) was also systematically recorded. Co-morbidities and 
results of investigations performed at presentation (before CTPA) were recorded. All 
patients provided a short history covering co-morbidities and potential risk factors for PE. 
Dates of discharge from hospital or death in hospital were recorded. Mortality data 
relating to the period after hospital discharge were obtained from the National Registry 
Office for Scotland. Patients’ details were matched to the national registry of deaths 
occurring in Scotland by name, date of birth, sex and post code. Matching was considered 
to be adequate if at least three of these characteristics concurred with a death recorded in 
the registry, and under these circumstances the patient’s death was considered to be 
confirmed.  
Patients were excluded if case records were unavailable throughout hospital admission or 
if the presence or absence of acute PE could not be confidently diagnosed at CTPA. If 
more than one CTPA was performed during the study period, only data from the first scan 
were included. Patients were excluded if they had a CTPA in the three months prior to the 
study period and had a follow-up CTPA during the study period that did not relate to a 
new presentation.    









The distribution of gender, previous PE and previous deep vein thrombosis ( DVT)  in the 
PE and the non-PE groups were compared using the chi-squared test. Comparisons of 
numerical variable in the PE and non-PE groups was performed using the Mann-Whitney 
U-test. A significance level of 0.05 was used.  
To obtain an estimate of the relationship between RV:LV ratio and MMS, the RV:LV 
ratio data for the PE group were tested for outliers.  Three extreme outliers more than 
87% higher than the median were eliminated. To minimise roughness caused by 
measurement uncertainty a smoothing procedure - the LOcally-WEighted Scatter plot 
Smoother, LOWESS - was then applied to a plot of RV:LV ratios versus MMS. Using 
polynomial regression analysis, a quadratic curve was fitted to the smoothed data using 
the statistical software package Minitab 14.  The resultant polynomial curve fitted to the 
smoothed data was tested using an F-ratio test with a significance level of 0.05. Using a 
bivariate model with two outcomes - occurrence or non-occurrence of PE - a binary 
logistic regression analysis was performed to test for factors differentiating PE and non-
PE patients at presentation, adjusting for confounding effects. Variables adjusted for in 
the binary logistic regression included age, previous PE, previous DVT, PaO2, PACO2. 
SaO2, hydrogen ion concentration in arterial blood, serum D-dimer, prothrombin time, 
serum C reactive protein, RV:LV ratio. Logistic regression analysis was performed using 
the statistical package SPSS 12.0.   





Figure 3 Extravascular radiological features detected at CTPA. *P<0.01 when 
comparing the two groups. 
 
RESULTS 
One hundred and ninety-four patients were admitted to hospital with suspected acute PE 
and had CTPA. Eight patients were excluded (two scans were indeterminate, two patients 
were transferred to another hospital before being seen by study investigators, and four 
were lost to follow up after transfer to other hospitals). Therefore data analysis was 
performed on 186 patients followed through to discharge from hospital or death in 
hospital.  
Forty-five patients (24.2%) had a diagnosis of acute PE at CTPA. With regard to whether 
PE was present or absent, no discrepancies were found in observations made by the study 
radiologist and the diagnostic service for any of the 186 scans.  





Baseline characteristics for the PE and ‘non-PE’ groups are shown in table 1. Patients 
with PE were significantly more likely to be male (P=0.020), to have higher circulating 
D-dimer (P<0.0005), and to have increased RV:LV ratio (P=0.037). However, when these 
factors were entered into binary logistic regression analysis and adjustments made for 
mutual confounding factors, only elevated serum D-dimer level remained significantly 
associated with PE (adjusted odds ratio 1.12, 90% confidence intervals 1.06-1.08).  




Significant co-morbidities were evenly distributed in patients with and without PE 
(Figure 2). Chronic Obstructive Pulmonary Disease (COPD) was more common in the 
non-PE group but this finding did not reach statistical significance ( P=0.101). Working 
diagnosis for the 141 patients with no evidence of acute PE is shown in table 2. 
No significant differences were found when comparing major pulmonary and pleural 
radiological abnormalities in patients with and without PE, with the exception of 
consolidation which was more common among patients with PE .  
There were seven deaths in hospital, all in the non-PE group (no significant difference 
between the groups). None of these seven patients had a post-mortem examination. In 
each case bronchopneumonia was listed as a cause of death, though three patients had 
another significant pathology (idiopathic pulmonary fibrosis, left ventricular failure and 
cancer). At 1 year all-cause mortality in the PE group was 3/45 (6.7%) as compared with 
19/141 (13.5%) in the non-PE group (no significant difference).  None of the deaths were 
attributed to PE.  
Among patients with PE the median MMS was six (range 1-16) and there was a 
significant positive correlation between MMS (reflecting thrombus load) and RV:LV 
ratio. Following LOWESS smoothing, a highly significant quadratic relationship (R
2
= 
0.99, p < 0.0005) was observed between MMS and RV:LV ratio (Figure 4). The fitted 
curve demonstrates convergence towards an approximate linear relationship for MMS 
scores of 10 or more. In patients with PE neither MMS nor RV:LV ratio were 
significantly correlated with length of hospital stay.  





Figure 4 Plot of quadratic fit to smoothed RV:LV data. RV:LV =0.003 MMS2 -
0.018 MMS +0.941. R2 = 0.99. Data apply only to patients with PE. 
 
DISCUSSION 
Our data suggest that patients with and without PE were strikingly similar with regard to 
comorbidities, clinical features at presentation and outcome. A retrospective study by 
Poulsen et al
20
, which relied on scintigraphy for the diagnosis of PE, found similar trends. 
The clinical implication is that patients presenting with clinical features compatible with 
acute PE have a relatively poor prognosis irrespective of whether PE is detected.  
 
 
Considering the group without PE specifically, our data suggest an all-cause mortality 
rate of 13% at 1 year with a trend towards this group having a worse prognosis than 
patients with PE. This can be compared with an all-cause 1 year mortality in 65-year olds 
in Scotland of 2.5% (personal communication, Ms. Marie Climson, General Register 
Office for Scotland). This trend supports data from a separate retrospective study 




performed by our group which showed that patients with an indeterminate lung 
scintigraphy scan had significantly worse prognosis than patients with a high probability 
scan over 5 years of follow-up
21
. The mortality figures presented here are broadly in 
keeping with the small number of studies that have quantified mortality in patients with 
diagnostic imaging that refuted PE, the emerging picture suggesting a 1 year mortality of 
around 15% but with venous thromboembolism responsible for only a small fraction of 
those deaths.
22-26
 Indeed, subsequent presentation with venous thromboembolism is well 
studied in this group of patients and reported rates are consistently low.
13-15
  The poor 
prognosis in patients without PE therefore seems likely to arise from the multiple co-
morbidities represented in this group, with an additional short-term contribution made by 
in-patient mortality caused by pneumonia. We believe that the clinically heterogeneous 
group of patients in whom suspected acute PE is refuted deserves further prospective 
study given the consistently poor overall prognosis emerging in the literature. Whether 
health professionals are aware of the poor prognosis of this cohort remains to be 
determined, but our anecdotal impression is that this is under-recognised. 
One interpretation of our findings is that treated PE itself makes little impression on the 
prognosis of patients presenting with ‘clinically suspected PE.’ An extension of this 
argument holds that if patients survive the haemodynamic insult of the acute embolic 
event to reach hospital and receive appropriate treatment, their prognosis is largely 
determined by their comorbidities rather than by effects of PE. This contention is 
supported by observations elsewhere.
5-7
 Interestingly, mortality rates among patients with 




PE were comparatively low in our study. The reasons for this remain unclear but may 
partly reflect the use of CTPA which can pick up smaller PEs with greater specificity than 
scintigraphy (used in several previous studies). Our data emphasise the usefulness of 
CTPA not only for diagnosis of PE, but for additional information that can be derived 
with regard to extravascular pathology.
17
 We found a high rate of consolidation at CTPA, 
this being significantly more common in patients with PE. Secondary consolidation has 
been recognised as a frequent accompaniment to PE before.
27-29
  
The similar clinical and radiological features of patients with and without PE confirm and 
emphasise the notorious difficulties in making the clinical diagnosis. In recent years pre-
test prediction models have made significant advances in identifying patients who are at 
very low risk of PE, do not require invasive imaging, and have a relatively good 
prognosis.
15, 30-33
 Identification of positive clinical predictors of acute PE would also be 
helpful. However, we only found elevated D-dimer concentrations to be significantly 
associated with PE. While these data must be interpreted with caution given the small 
number of patients for whom data were available, D-dimer concentrations have been 
found clinical utility as a negative predictor for PE
30.33.34  
and high concentrations have 
been associated with larger thrombi.
35
  
The PE group in our study was also found to have a higher RV:LV ratio , which is a well 
recognised consequence of acute pulmonary arterial obstruction The ratio correlated 
closely with thrombus load, the relationship appearing to be particularly strong above a 
MMS of 10. This observation is in keeping with the concept that there is a break point 




below which the right ventricle copes with increased pulmonary vascular resistance, but 
above which acute dilatation proceeds. Right ventricular dilatation, increasing thrombus 
load and interventricular-septal bowing have been identified as adverse prognostic factors 
in acute PE.
36-38
 Measurements of RV diastolic dimensions on axial multi-slice CT scan 
have been found to correlate with outcome,
39
 and CT dimensions have been shown to 
correlate with findings using transthoracic echocardiography. 
40.41
 
We acknowledge several limitations of our study. In particular the study is relatively 
small. Other limitations relate to the decision to make the study design entirely 
observational and ‘non-interventional’, i.e. investigators were not permitted to influence 
investigations or management in the expectation that the study would reflect ‘real life’ 
clinical practice (thereby having greater general applicability). In addition, data were not 
complete for each variable studied, as the decision whether to perform an investigation 
(e.g. D-dimer) was entirely dependent on attending physicians. Furthermore, we cannot 
determine how many patients considered initially to be at high clinical risk of PE were 
not submitted for CTPA on the grounds of a low probability clinical prediction score. 
Therefore our data should only be interpreted in the setting of patients in whom clinical 
suspicion was sufficient to warrant a CTPA. Similarly, detection of mortality out of 
hospital was reliant on hospital-recorded demographics matching those held by the 
Registrar General for Scotland (responsible for collating all deaths in Scotland). The main 
confounding factor for this system would arise if a patient died outside Scotland (e.g. a 
visitor to Scotland who died on returning home, or a Scottish resident who died whilst 




visiting another country). We have no data to suggest either eventuality arose. While we 
believe it is unlikely that mortality rates were biased by these factors, we acknowledge 
that cause of death as determined by death certificates are notoriously inaccurate. Whilst 
recognising the relevance of all these limitations we have no reason to believe that biases 
should be specifically over-represented in either group of patients studied. 
In summary, patients with clinically suspected PE have a poor prognosis regardless of 
whether PE is confirmed on definitive imaging and comprise a group deserving of further 
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COPD  Chronic obstructive pulmonary disease 
CT   Computed tomography  
CTPA  Computed tomographic pulmonary arteriography 
CXR  Chest x-ray 
LV  Left ventricle/ventricular 
MMS  Modified Miller score 
PaCO2  Partial pressure of carbon dioxide in arterial blood 
PaO2   Partial pressure of oxygen in arterial blood 
PE  Pulmonary embolism 
RV  Right ventricle/ventricular 
RV:LV ratio Ratio of the dimensions of the right ventricular and left ventricular 
cavities 
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The utility of D-dimer in the diagnostic workup of pulmonary embolism has been 
established. Several D-dimer tests are available with different sensitivities and 
specificities.  SimpliRED D-dimer is a rapid qualitative whole blood D-dimer assay 
suitable for bedside use. 
Objective: 
 To assess the value of SimpliRED D-dimer test in patients with suspected acute 
pulmonary embolism investigated with CTPA in the absence of formal ‘risk scoring’ 
Design:  
A prospective study measuring SimpliRED D-dimer in unselected patients undergoing 
computed tomographic pulmonary angiography (CTPA) examination for suspected acute 
pulmonary embolism. 
Main outcome measures:  
D-dimer and CTPA results were compared. Sensitivity, specificity, and positive and 
negative predictive values of SimpliRED D-dimer were calculated for the unselected 
patient group. 





 Forty-seven patients had valid D-dimer and CTPA. SimpliRED D-dimer was positive in 
23 and negative in 24 patients.  D-dimer was positive in only 6 (50%) of the 12 patients 
with positive CTPA, only 6 had positive. Of the 35 with negative CTPA, 17 had positive 
D-dimer. Sensitivity of SimpliRED D-dimer was 50.0% and specificity 51.4%. The 
positive predictive value of the D-dimer was 26.1 % and the negative predictive value 
75.0%.  
Conclusion: 
 SimpliRED D-dimer should not be used in the diagnosis of pulmonary embolism in the 
absence of risk scoring. 
 
Introduction 
The diagnosis of pulmonary embolism (PE) can be difficult. The incidence of clinically 
suspected PE is estimated at 2-3 per 1000 per year in the western world
1,2
 and only a third 
of these clinically suspected cases actually have a PE.
3-5
 Diagnostic imaging is required to 
confirm or refute the diagnosis. Computed tomographic pulmonary angiography (CTPA) 
is a sensitive and specific imaging test for diagnosis of pulmonary embolism. As the 
diagnosis is confirmed in only about 25% of suspected cases,
5,7-8
 clinical algorithms have 
been developed
6 
to reduce the need for diagnostic imaging. 




D-dimer, a degradation product of cross-linked fibrin, is raised in several conditions 




 A combination of negative D-dimer results combined with a 
low clinical probability of PE can safely the presence of pulmonary embolism without the 
need for further imaging tests.
12
 D-dimer testing has been included in the diagnostic 
algorithm in the British Thoracic Society (BTS) guidelines for the management of 
suspected acute pulmonary embolism.
6
  
The SimpliRED assay (Agen Biomedical Ltd., Brisbane, Australia) is a rapid qualitative 
whole blood D-dimer assay suitable for bedside use. The overall specificity of this test to 
be 68.4% with an overall negative predictive value of 85%.
13
Furthermore this assay was 
used in the original validation study for the Wells Score,
12
 which is now widely used in 
the calculation of pre-test probability of the diagnosis.  
 
Objectives   
To determine whether  SimpliRED D-dimer could be used as a means of reducing CTPA 




A prospective study was performed on 48 patients who had been referred to the radiology 
department for CTPA for investigation of suspected acute pulmonary embolism. None of 




these patients had undergone formal assessment of pre-test clinical probability. The 
SimpliRED D-dimer test was performed on venous blood in the radiology department 
when the patient attended for the CTPA. The Radiologist, who was blinded to the results 
of the D-dimer assay,  reported the CTPA as positive or negative for pulmonary 
embolism. The results of D-dimer and CTPA were later compared.  
Results 
Forty-eight patients underwent D-dimer and CTPA, males 19 (39.6%) and females 29 
(60.4%). D-dimer was deemed invalid for technical reasons in one male patient and was 
taken out of analysis. 
SimpliRED D-dimer was positive in 23 and negative in 24 patients.  CTPA was positive 
in 12 and negative in 35 patients. Out of the 12 patients with positive CTPA, 6 had 
positive D-dimer. Of the 35 patients with negative CTPA, 17 had positive D-dimer and 
the rest had negative D-dimer. (table 1) 
The prevalence of pulmonary embolism in the study population was 25.5%. The 
sensitivity of SimpliRED D-dimer was 50.0% and the specificity 51.4% with the test 
accuracy of 51.1%. The positive predictive value of the D-dimer was 26.1 % and the 









Table 1. Results of SimpliRED D-dimer test and CTPA 
 
                                                                                                          CTPA 
 
 
SimpliRED     
D-dimer 
 Positive  Negative Total 
Positive 6 17 23 
Negative 6 18 24 




The results of this study re-enforce the dangers of interpreting D-dimer results in the 
absence of formal risk scoring. Current guidelines recommend the use of blood D-dimer 
assay only following assessment of clinical probability, and not performed in patients 
with high clinical probability.
6
 A negative D-dimer test is valuable in excluding 






In our study, the specificity as well as the negative predictive value of SimpliRED D-
dimer test was much lower compared to the previous studies
13
. The test was done 
independent of clinical probability and as such the test did not prove to be useful in 
excluding pulmonary embolism in this study population. This is however still seen in 
clinical practice with D-dimer tests often ordered at point of entry to care without clinical 




probability being fully assessed and at times compounded by radiology departments 
wishing to know the result prior to proceeding to imaging.  
The practice of indiscriminate D-dimer testing without an assessment of clinical 
probability is not useful or acceptable. This study suggests that SimpliRED D-dimer in 
the absence of a clinical probability score has no greater predictive value for PE than the 
toss of a coin. However the test has previously shown a negative predictive value of 
99%
13 
when used in a subgroup of patients with low clinical probability. This highlights 
the fact that, when used properly and in conjunction with clinical probability scores, the 
test remains useful. 
There are several different assays available to measure D-dimer levels. The SimpliRED is 
a rapid qualitative red cell agglutination test with low specificity and sensitivity as 
explained above. Rapid quantitative ELISA (Vidas) has been useful even in patients with 
intermediate clinical probability but has a low specificity.
6
 MDA D-dimer has a better 




A negative SimpliRED D-dimer assay in isolation does not safely exclude the diagnosis 
of a pulmonary embolism. It is imperative that the test result is always interpreted in the 
context of clinical probability scoring.  
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Aim To quantify the incidence of unsuspected pulmonary emboli (PE) in an unselected 
in-patient population undergoing contrast enhanced multi-detector CT (MDCT) thorax 
and to assess aetiological factors in their development. 
Materials and Methods All in-patients undergoing MDCT thorax over a ten month 
period were prospectively identified. Patients with previous or suspected current PE were 
excluded. CT scans were reviewed and the degree of contrast enhancement and presence 
of PE recorded. Where PE was found the level of most proximal thrombus was identified. 
Patient age, length of admission, slice scan thickness and clinical indication was noted.  
Results 547 in-patients having undergone MDCT were identified. Following exclusions 
487 remained. 5.7% (28/487) demonstrated PE. Unsuspected PE was more common with 
increasing age (p<0.001), identified in 9.2% (20/218) of all patients over 70 years and 
16.7% (11/66) of over 80 year olds. 64.3% were at segmental or sub-segmental level. No 
other aetiological factor was identified which significantly increased the incidence of 
unsuspected PE. No significant difference was noted between 4- and 16-slice MDCT. 
32.1% of incidental PE were not identified by the original reporting radiologists. 
Conclusion PE is an unsuspected finding on contrast enhanced MDCT thorax in 5.7% 
of all in-patients. This includes an incidence of 9.2% in patients > 70 years rising to 
16.7% in over 80 years old. Most are peripheral and >30% are missed on initial review. 




PE should be routinely sought in all contrast enhanced MDCT of the chest irrespective of 
the indication for the scan. 
INTRODUCTION 
Pulmonary embolism (PE) is a common disease estimated to be a contributory factor in 
approximately 200,000 deaths per year in the United States, occurring in 5-10% of 
hospital deaths.[1] PE is a difficult disease to positively diagnose clinically, presenting 
with varied and sometimes minimal symptoms that mimic a myriad of other pathologies. 
The actual annual incidence of PE is therefore difficult to determine but has been 
estimated at around 60-70 per 100,000 people.[2] 
In the past PE was only ever firmly diagnosed after the diagnosis had been first 
considered by a clinician then proven by radiological study; either an isotope perfusion 
lung scan, a conventional pulmonary angiogram or in recent years a CT pulmonary 
angiogram (CTPA). With the advent of multidetector CT (MDCT), which allows 
assessment of the chest with thin section collimation using rapid acquisition, it is now 
possible to visualise the pulmonary arterial tree down to sub-segmental level on most 




Over a period of 10 months from 1
st
 January 2004 to 13
th
 October 2004, consecutive in-
patients undergoing contrast enhanced MDCT chest for an indication other than suspected 




PE, were identified at a large teaching hospital. In-patients were selected for the patient 
study group as this was the population thought to be most at risk and in whom it was 
considered most likely that unsuspected PE might be detected. Patients were scanned 
either using either a 4 or 16 slice scanner (both Toshiba Aquilion series, Toshiba Medical 
Systems, Tokyo, Japan).  
Patient details were recorded for the purpose of identification of the computer images and 
for accessing demographic information from the hospital database. From the request card, 
logbooks and hospital database, record was made of age, referring speciality, date of 
admission (to calculate length of hospital stay prior to scanning), scan slice thickness and 
brief clinical information or reason for referral.  Recruited patients were hospital in-
patients, from the wards, Admissions unit, Day Case Unit or Accident and Emergency 
(excluding trauma cases). Patients were excluded if they were suspected or known to have 
had a PE. CTPA studies were not included.  
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Table 1: Scan Parameters 
 





Scan protocol varied depending on the indication for study. In most studies 100mls 
iodinated contrast was injected at between 3 and 4 mls per second with the scan 
commencing at around 20 seconds post start of the contrast injection. Scan parameters are 
outlined in Table 1.  
 
Tube current (mA) is not given as this is controlled by in-built dose modulation software 
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Figure 1. Proximal extend of thrombus in the study population 
 
 





All studies were initially reported as per routine practice in our institution. Subsequently, 
a single Consultant Thoracic Radiologist who was blinded to the initial report reviewed 
the studies. All images were assessed using a workstation allowing multi-planar 
reformatting.  For each patient the degree of contrast enhancement and presence or 
absence of PE was noted.  
 
 
Figure 2 Sub-segmental thrombus in the right lower lobe  




If the scan was positive the level of thrombus was recorded as central, lobar, segmental or 
sub-segmental. Contrast enhancement was classified as good (good enhancement of 
segmental and sub-segmental arteries), moderate (good enhancement of segmental but not 
of sub-segmental branches) or poor (inadequate enhancement of entire pulmonary arterial 
tree). Patients were excluded from the study at this stage if there was poor or absent 
contrast enhancement, if the lungs were only partially imaged or the images were not 
retrievable on the workstation (technical difficulties). 
If scans were found to demonstrate pulmonary emboli which had not previously been 
reported, the appropriate clinical team were informed.  
 
 
Age Number Number Positive 
 
% Positive 
<50 yrs 47 0 0 
50-59 75 3 4 
60-69 147 5 3.4 
70-79 152 9 5.9 
>80 66 11 16.7 
 
Table 2: Age Distribution of Studies 
 
RESULTS 
During the study period 547 consecutive in-patients undergoing MDCT thorax were 
identified from the scanner logbooks. 16 patients were excluded due to absence of 




intravenous contrast, 25 due to incomplete lung imaging and 19 were excluded due to 
poor contrast enhancement.  
Following exclusions a population of 487 study patients remained. These subjects were 
the in-patients with good or moderate contrast enhancement of the pulmonary arteries and 
no suspected or prior history of PE. Study group included 200 female (41%) and 287 
male patients (59%). Median age 69 years (range 15-93 years). 28/487 scans 
demonstrated pulmonary emboli, an incidence of 5.7% in the total study population. 
20/218 patients over 70 years old had unsuspected PE, an incidence of 9.2% in this 
cumulative grouping. This rises in the over 80 year age group to an incidence of 16.7% 
(11/66).  
Median age of all patients with positive scan was 77 years, range 52-88 years. There was 
a statistically significant association between age group and the rate of unsuspected PE 
(χ
2
=13.28, p=<0.001) with a significant difference in rate of PE with increasing age. The 
distribution of PE by age is recorded in table II although for the purposes of analysis the 
<50 and 50-59 age groups have been combined. 
Of the positive scans, 27/28 (96.4%) showed good contrast enhancement, the one scan 
which showed only moderate enhancement had thrombus at a segmental level. 
402/487 (82.5%) of the study patients were scanned on a 16-slice scanner, and images 
reconstructed at 1mm thickness, the incidence of PE among this subgroup was 24/402 
(6.0%). 85/487 (17.5%) patients were scanned on a 4-slice scanner with slice 




reconstructions at either 2mm or 3mm. A total of 4/85 scans were positive for PE, an 
incidence of 4.7%. Of these, 3 were scanned with 3mm slice thickness. No statistically 
significant difference was noted between 4 and 16 slice scanners in their ability to 
identify unsuspected PE (p=0.80 using Fishers exact test).  
 
 
Figure 3 Segmental level thrombus 
 
Distribution of proximal thrombus in the entire population is shown in Figure 1. Image 1 
is an example of sub-segmental thrombus in the right lower lobe, Image 2 demonstrates 
segmental level thrombus and Image 3 shows more proximal PE in the main pulmonary 
arteries bilaterally, all were unsuspected. 






Figure 4 Thrombus in the main pulmonary artery 
 
19/28 (67.9%) of pulmonary emboli were positively identified on initial report. Of the 9 
positive studies not identified at initial review, thrombus was segmental in 6 cases and 
sub-segmental in 3 cases. Distribution of involved lobes is summarised in figure 5. 
Referral speciality and clinical information given on the request card was used to 
determine any prior risk. The presumptive diagnosis of all patients at referral is 
illustrated in figure 6. Most referrals, accounting for just over a third, were from 
the respiratory physicians (166/487), the general surgeons and general medical 




teams accounted for just over 10% of referrals each, with fewer referrals from GI 


































































Figure 5: Site of Thrombus in study population 
 
Cancer refers to any patient with known or suspected cancer, mediastinal or pulmonary 
mass. Collection covers patients being imaged to evaluate pleural or pericardial 
collections. Infection includes patients with slow to resolve pneumonia or sepsis. 
Transplant identifies a group of patients being assessed for hepatic and renal 
transplantation. Aneurysm covers patients with thoracic aneurysm as well as patients 
suspected of having acute aortic syndrome. Miscellaneous describes a heterogeneous 
group with diverse presumptive diagnoses including pulmonary fibrosis, emphysema, 
collapse, hoarseness and dysphagia .Studies were performed as determined by clinical 
urgency, based largely on information provided on patient request card. 





Figure 6: Presumptive Diagnosis at Referral  
At our institution the vast majority of in-patient CT scans are performed within 3 days of 
request. Of the positive studies 18/28 (64.3%) were carried out for confirmed or 
presumed malignancy. Of the total study population, 343 studies (70.4%) were carried out 
for confirmed or presumed malignancy. There was no evidence of a statistically 
significant difference in the proportion of PE cases in those with suspected malignancy 
(18/343, 5.2%) compared to the proportion of PE in non-malignancy (10/144, 6.9%).  
Difference in proportions is -1.7% with a 95% CI for difference (-6.47%, 3.08%), 
p=0.486 (binomial test for proportions).  















































Median duration of in-patient admission prior to scan was 3 days, (range 0-255 days). 
Distribution of hospital stay for positive scans is recorded in Figure 7.  
Looking at grouped hospital stays (0-1, 2-3, 4-6 and 7+ days) there was no statistically 
significant relationship between length of hospital stay and likelihood of finding 
unsuspected PE (χ
2
=2.169, p=0.538)  
 
DISCUSSION  
Terminology and Significance of Unsuspected PE  
Previous studies[3,4] have described the finding of pulmonary embolism, in situations 
where this is not suspected, as incidental  PE. In this study we have chosen to use the 
term unsuspected PE, previously also used by Gosselin et al.[5] The term incidental to 
some suggests clinical insignificance. We feel there is little evidence to support the 
implication that these emboli are necessarily of less clinical significance just because they 
are identified as an incidental finding.  
 Recent meta-analysis of necropsy studies has demonstrated that pulmonary embolism 
remains a common condition where there is discrepancy between clinically suspected and 
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Figure 7. Days in hospital prior to diagnosis of PE 
necropsy proven cause of death.[6] The significance of small pulmonary emboli has been 
called in to question. While discussion as to the importance of small emboli is beyond the 
scope of this article, a comprehensive summary of the evidence regarding small 
pulmonary emboli is contained in a recent editorial by Goodman.[7] It is of note that of 
the emboli identified in this study,  18/28 were at segmental or  sub-segmental level and 
might  be classified as small. 
 
Identification and Estimates of Prevalence of PE 
Contrast enhanced CT, specifically CTPA, has become the first line investigation in  
many centres in the diagnosis of pulmonary embolism due to a high inter-observer 
agreement,[8] identification of unsuspected pathologies[9] and because it is a cost 
effective method of imaging PE.[10] 
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Unsuspected PE has previously been demonstrated in patients undergoing contrast 
enhanced CT of the chest for reasons other than suspected PE. Using older technologies in 
a study of 1879 patients undergoing contrast enhanced helical CT thorax, Winston et al[4] 
identified 18 patients with unsuspected PE, estimating the prevalence at 1%. A similar 
study by Gosselin et al[5] demonstrated an overall rate of 1.5%, with up to 5% of in-
patients demonstrating PE. More recently, with a 4 slice MDCT, Storto et al[3] found 
incidental PE in 4% of 474 in-patients. No previous studies have reported rates of 
unsuspected PE using 16-slice MDCT. 
 Our study has shown an overall rate of unsuspected PE of 5.7%. We identified only those 
in-patients in whom PE was an unexpected finding. Due to the exclusion of CTPA 
examinations and patients with a known PE, this figure must be an underestimation of the 
actual prevalence of PE in the hospital population. The fact that we are now identifying 
these unsuspected PE on a regular basis implies that PE is much more common than 
previously appreciated. Many of the unsuspected PE, were in the smaller segmental and 
sub-segmental arteries. Whilst large central PE may seem more likely to be clinically 
apparent, peripheral emboli are also important because of the tendency to cause 
pulmonary infarction, pleuritic chest symptoms and as a possible prelude to larger 
potentially life threatening emboli. Until the natural history of these smaller PE is better 
understood it remains the responsibility of the radiologist to report them and of the 
clinician to define the therapy. We cannot conclude from this study whether or not 
patients with unsuspected PE should be anti-coagulated or not. We would expect that the 
larger emboli at least require treatment. Evidence is uncertain as to optimal management 
so far as the smaller asymptomatic emboli are concerned. In our institution clinicians 
certainly still consider all detected PE as significant and treat as such. The question which 
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our study does raise is whether PE, and in particular small PE, are more common than 
previously recognised. If this is the case then these small PE may be of lesser clinical 
significance than larger clinically evident PE and may merit a different management 
strategy. A possible strategy, which would need to be fully evaluated, would be to do leg 
U/S in patients with unsuspected or asymptomatic emboli, to look for possible DVT and 
avoid anticoagulation if negative. 
 
 
Spatial Resolution and Identification of PE 
The higher incidence of PE demonstrated in our study compared to previous studies may 
be due to improved spatial resolution. Previous work has indicated that MDCT increases 
conspicuity of small, peripheral arteries.[11,12] Several studies have also demonstrated 
increased sensitivity for detection of pulmonary embolism in sub-segmental vessels using 
MDCT.[13-15] Patel et al[16] have previously demonstrated that MDCT scanning 
demonstrates more PE and in smaller vessels than single slice scanning. In addition, the 
same study demonstrated that using MDCT decreasing slice thickness from 2.5mm to 
1.25 mm improved visualisation of segmental and sub-segmental vessels and PE.  
If spatial resolution is the principal determining factor in identification of peripheral 
emboli, it is perhaps not surprising that our data demonstrates more incidental PE in 
patients scanned using a 16 slice scanner with 1mm slice thickness than in a 4 slice 
scanner with a 2 or 3mm slice thickness. The difference in this study between 4 and 16-
slice scanning was not statistically significant. This likely reflects the small number of 
positive studies identified. 
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In this study, only 67.9% of the positive scans were initially reported as showing PE. In 
all 9 cases (32.1%) where PE was not identified, thrombus was at segmental level or more 
distally. These data suggests that smaller clots are more easily overlooked and highlights 
the need to include a thorough assessment of pulmonary arteries in all contrast enhanced 
thoracic CT scans.  
 
Aetiological Factors in Unsuspected PE 
Age: 
Older patients are significantly more likely to develop symptomatic thrombo-embolic 
disease.[2,17,18] This study demonstrates that older people are also more likely to 
develop unsuspected PE. Most dramatically illustrated, in the over 80 age group who were 
found to have PE in 16.7% of cases (Table II). We recognise that age may be a surrogate 
for other risk factors known to be associated with an increased risk of PE such as 
malignancy, immobility or heart failure.  
Malignancy: 
The suggestion that rates of incidental PE are higher in patients with confirmed or 
presumed malignancy is not new. In a sub-group assessment following the PIOPED study, 
14 of 20 patients proven to have unsuspected pulmonary embolism as the principal cause 
of death at autopsy had advanced associated diseases, with malignancy in 4 patients.[19] 
The link between thrombo-embolic disease and malignancy is further suggested by the 
finding of an increased risk of the diagnosis of malignancy in the 2 years following 
diagnosis of venous thrombo-embolism in a large retrospective study.[20] In a recent 
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paper regarding incidental PE, Storto et al have noted that 70% of patients with incidental 
PE had malignancy.[3] 
 
No statistically significant correlation between malignancy and incidence of PE was noted 
in this study. The reasons for this are uncertain but may reflect in part the small number of 
positive cases and the fact that the great majority of patients having a contrast enhanced 
CT of thorax fell into this category and that many of the scans were for presumed, rather 
than confirmed malignancy. 
 
Hospital Admission: 
No significant association is seen in this study between length of hospital admission and 
presence of PE. Hospital in-patient stays are now relatively short. The average stay for all 
patients scanned in this study was only three days and 17 of the 28 positive cases were 
identified within five day of admission. We would suggest that at least some of these 
emboli had been present prior to admission. We would also suggest that for patients with 
longer admissions, the use of low molecular weight heparin (LMWH) as prophylaxis 
might have a protective effect, this information however was not easily available during 
this study. 
The rate of unsuspected in-patient PE will not reflect the general out-patient incidence. 
This population theoretically should have fewer risk factors for PE and therefore 
presumably a lower incidence.[3]  
A small number of outpatient scans were inadvertently assessed before exclusion from our 
study. Of 43 such studies, 4 patients (9.3%) showed incidental PE. This is at odds with the 
suggestion that prolonged hospital admission increases the rate of PE, but is felt likely to 
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be spuriously high due to small patient numbers involved and a larger study is needed in 




Unsuspected PE is present in 5.7% of in-patients having contrast enhanced MDCT thorax. 
The detection of these thrombi suggests that the actual prevalence of PE in the hospital 
population is greater than previously appreciated. The incidence increases significantly 
with age with 9.2% of the over 70 year old, and 16.7% of the over 80 year old population 
affected. We showed no statistical correlation with the length of admission or associated 
malignancy.  
In this study >30% of emboli are missed on initial review, all of these were found in 
segmental or sub-segmental vessels, but the clinical significance of these smaller thrombi 
remains uncertain. Routine assessment of the pulmonary arteries should be considered 
standard practice when reporting any contrast enhanced MDCT thorax. 
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To evaluate the incidence of unsuspected pulmonary embolism (PE) in an unselected 
population of outpatients undergoing contrast-enhanced multi-detector computed 
tomography (MDCT) for indications other than the investigation of PE. 
 
Materials and methods  
Outpatients undergoing CT of the chest over a 6-month period were retrospectively 
identified and images reviewed. Inpatients and patients undergoing unenhanced CT of the 
chest were excluded. Data, including referring specialty, patient age and sex, reasons for 
examination, level of embolism, image quality, and section thickness were recorded. 
Radiology reports were reviewed with respect to whether or not the embolism was noted 
at the time of initial reporting. 
 
Results  
Following exclusions 440 patients were reviewed (195 women and 245 men). PE was 
identified in 10 of the 440 patients, an incidence of 2.23%. One pulmonary embolus was 
in the main pulmonary artery, three were in lobar arteries, three in segmental arteries, and 
three in sub-segmental arteries. Patients over the age of 60 years were more likely to have 
an embolism (9/300, 2.9%) compared with those under 60 years (1/140, 0.7%). Seven of 
the 10 positive examinations were carried out in patients who were known or later shown 
to have malignancy. Seven of the 10 emboli were reported at the time of initial reporting. 





The outpatient population has a significant incidence of unsuspected PE. PE should be 
actively sought when reporting examinations performed for alternative indications, 
particularly where cancer is a known or suspected diagnosis. 
 
Introduction   
Pulmonary embolism (PE) is a common condition with a documented annual incidence of 
500 000 cases in the United States, [1] and is responsible for considerable morbidity and 
mortality. The advent of thin-slice multi-detector CT (MDCT) has led to the diagnosis of 
unsuspected pulmonary emboli being made in contrast enhanced CT examinations of the 
thorax where there was no clinical suspicion of pulmonary emboli. It is therefore 
important that radiologists are aware of the capability of their modality in diagnosing 
unexpected pulmonary emboli and actively seek to exclude the diagnosis on all contrast 
enhanced CT chest scans whatever the indication.  
 
Previous studies have highlighted an incidence of unsuspected PEs of up to 5.7% in high 
risk populations such as cancer patients and inpatients.
 
[2,3,4,5]  Silent PEs are also well 
described in patients with deep vein thrombosis [6,7,8].The aim of this study is to 
investigate the incidence of unsuspected pulmonary emboli in  outpatients undergoing 
routine contrast enhanced MDCT of the chest. We also aim to evaluate the aetiological 
factors relating to PE in outpatients and to compare the enhancement and diagnostic utility 
of the 4 and 16 slice scanners.  




Materials and Methods 
Outpatients undergoing CT of the chest for indications other than suspected pulmonary 
emboli over a 6 month period were retrospectively identified and analysed within one 
week of the scan being performed. Data including the referring specialty, age of the 
patient, indication for scan, most proximal level of the embolism, quality of the scan and 
scan slice thickness were documented. The radiology reports were reviewed with respect 
to whether or not the embolism had been noted at the time of initial reporting. Patients 
were scanned using either a 16-slice or a 4-slice scanner, (Toshiba Aquillion Series, 
Toshiba Medical Systems, Tokyo). Patients who had been referred for outpatient 
investigation by a range of medical and surgical specialties were included. Inpatients and 
non contrast scans were excluded, as were patients with a past history of venous 
thromboembolism. 
Institutional approval was obtained for the study.  
 
Imaging Protocols 
The parameters used for the scan depended on the indication for the study. Most studies 
were performed using a standard protocol with 100mls of iodinated contrast medium 
injected at a rate of 3-4mls/second with scanning performed in a single breath hold 20 
seconds after the start of contrast injection. 1mm thick images were reconstructed using 
the 16 slice scanner and 2-3mm slice thickness for the 4 slice scanner. Scan protocols 
employed are outlined in table 1.  
 
 




All images were routinely reported at the time the study was performed. Images were re-
examined for this study using a 3-D workstation within a week of the examination being 
performed by one of 2 radiology registrars under supervision of a consultant 
cardiothoracic radiologist who reviewed all the positive and equivocal scans. The 
radiologists were blinded to the initial report. CT scans were assessed for the presence of 
pulmonary embolism and the location of the most proximal thrombus in the central,lobar, 
segmental or sub-segmental pulmonary arteries, recorded. The radiologist reviewing the 
scan also noted whether the contrast opacification of the pulmonary  
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Table 1 Imaging parameters 
 
arteries was good (good enhancement of segmental and sub-segmental pulmonary 
arteries), moderate (good enhancement of segmental but not sub-segmental pulmonary 
arteries) or poor (poor enhancement of the entire pulmonary arterial tree). Patients who 
had poor contrast enhancement were excluded from the study.  






Among the 449 scans evaluated 440 (97.8%) were considered to have good (n=395) or 
moderate (n=45) pulmonary artery opacification. 9 scans showed poor contrast 
enhancement and these were excluded from further study.  Of the 440 patients remaining 
195 (44.3%) were female and 245 (55.7%) male. The age range of patients was 19 to 94, 
median age 67.   
 
Figure 1. Proximal extent of thrombus. 
 
PE was discovered using CT in ten of the 440 patients, an overall incidence of 2.23%. The 
proximal extent of thrombus is shown in figure 1. One pulmonary embolus was in the 
main pulmonary artery, 3 were in lobar arteries, 3 in segmental arteries and 3 in sub-
segmental arteries. 7 of the 10 pulmonary emboli were identified at the initial time of 
reporting. The emboli which were not identified were all sub-segmental and the clinical 
teams were informed within a week of the scan being performed.  
 
 
Insights into VTE                                        John T Murchison                                                      
 
 103 
Age (years) n No. positive Percent positive 
<50 58 0 0 
50–59 80 1 1.3 
60–69 113 6 5.3 
70–79 135 2 1.5 
>80 54 1 1.9 
 
Table 2. Age distribution of patients. 
 
The age distribution for all patients is shown in table 2. Patients over the age of 60 were 
more likely to have an unsuspected pulmonary embolus (9/300, 3%) compared to those 
aged under 60 (1/140, 0.7%) but this was not a statistically significant finding (Fisher’s 
exact test, p=0.1853).  
The majority of patients who underwent outpatient CT of the thorax were referred by 
chest physicians (227/440) or by general surgeons (154/440). Of the 10 patients who had 
pulmonary emboli, 5 were referred by the chest physicians, 4 by general surgeons and 1 
by orthopaedics The indication for the majority (77.7%) of the scans was investigation of 
known or suspected cancer (342/440). 7 of the 10 positive scans were carried out in 
patients who had known malignancy or where later proved to have malignancy. There was 
a similar proportion of positive scans in patients with malignancy (6/342, 1.7%) and in 
those being investigated for other conditions (1/98, 1.0%, p=1.0) although numbers of 
positive cases were small.  





Enhancement of the pulmonary arteries using the four and 16-section machines. 
 
The four-section machine was far more likely to show poor or moderate enhancement of 
the pulmonary arteries when compared with the 16 section machine. Of the 367 patients 
scanned on the 16 slice scanner only 10 (2.7%) showed moderate enhancement of the 
pulmonary arteries and 3 (0.8%) showed poor enhancement while 354 (96.5%) showed 
good enhancement. Of the 82 patients scanned on the 4 slice scanner 35 (42.7%) showed 
moderate enhancement, 6 (7.3%) showed poor enhancement of the pulmonary arteries and 
41 (50%) showed good enhancement. Contrast enhancement is illustrated in figure 2. 
These numbers include the scans which showed poor enhancement of the pulmonary 
arteries, which were excluded from the remainder of the analysis above. 
Three hundred and sixty-four of the patients included in the study were scanned on the 16-
slice scanner and 76 patients on the 4 slice scanner. Two of the scans which were positive 
for PE were performed on the 4 slice scanner. One of these showed a PE in a lobar artery 
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and one in a segmental artery. There was no difference in the proportion of scans positive 
for PEs using the 4 slice (2/76, 2.6%) or the 16 slice (8/364, 2.2%) scanner provided the 
contrast enhancement of the pulmonary arteries was adequate (p=0.69), however all the 
unsuspected sub-segmental PE’s were detected using the 16 slice scanner. 
 
Discussion 
Of the outpatient population undergoing CT thorax in the present study, 2.2% had 
unsuspected PEs. The incidence of PEs is higher than in previously published studies that 
used thicker collimation, but lower than in the inpatient population for the same 
institution. The findings of the present study raise the likelihood that PE may be a more 
frequent event in the hospital outpatient population than was previously recognized. 
Our institution does not manage the bulk of the oncology work for our region (with the 
exception of upper gastrointestinal, hepato-biliary, and some chest oncology). Allowing 
for this, there are still a very high proportion of patients being investigated for malignancy 
(77.7%). The number of positive examinations in this study was too small to permit 
detailed analysis of this group. A larger study with greater numbers of positives would be 
necessary to draw more significant conclusions regarding the characteristics of the 
patients with unsuspected PEs. It has been shown that the older population is more likely 
to develop thromboembolic disease
2 9,10,11
 and although more PEs were found in the over 
60 years age group, this only represents a suggestion of an age effect and is not supported 
by statistical analysis. The lack of a statistically significant effect of age may be related to 
the relatively small number of patients and small number of positive results. There was no 
relationship between PE and referral specialty. 




Figure 3 74 year old with unsuspected right main pulmonary artery embolus. 
The clinical significance of these unsuspected PE remains unclear. One of the patients had 
a lobar embolus (Fig. 3), and there was no reason to suppose that unsuspected large 
central or lobar emboli are of any less importance than those that present with clinical 
symptoms. The majority of the unsuspected PEs in the present study were small, 
occurring at the segmental or sub-segmental level (Figure 4, Figure 5) and the clinical 
significance of these smaller PEs is less certain. In one study of patients without previous 
cardiovascular disease, the arm of patients randomized to receive no anticoagulation 
following silent PE did not show any adverse outcome compared with those who were 
treated.
8
 One of the physiological functions of the lung is to act as a filter for embolic 
particles to prevent their passage into the systemic circulation.
12
 However, there is a belief 








Figure 4. A 66year-old man with a subsegmental pulmonary embolus. Thisd was 
not seen at the intial time of reporting. The clinical team were informed of the 
finding 1-week later. 
These small events may also play a role in later development of thromboembolic 
pulmonary hypertension. At our institution all unsuspected emboli are currently managed 
with anticoagulation in the same manner as any embolus that is diagnosed following 
investigation to look specifically for PE. It remains to be seen whether in the future 
clinical practice may change in the management of these smaller unsuspected emboli. 
A recent study at our institution showed an inpatient rate of unsuspected PE of 5.7%.
2
 
This rate almost certainly underestimated the true prevalence of PE in the inpatient 
population as patients being investigated for PE were not included. The present study has 
found the rate of unsuspected PE in the hospital outpatient population to be 2.2%. Patients 
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with known or suspected thromboembolic disease were also excluded from this study, so 
this may also be an underestimation. 
It can probably be assumed that the outpatient hospital population has more risk factors 
for PE than the general population and indeed 77.7% of the present study population were 
under investigation for known or suspected malignancy, which is a widely accepted risk 
factor. Although not unwell enough to warrant admission to hospital, outpatients have co-
morbidities and are likely to be less mobile than the general population.  
The first studies to describe the frequency of “incidental” PE detected on CT tended to 
show lower rates of PE than more recent studies. Winston et al.
13
 found an incidence of 
unsuspected PE of 0.4% in 1996 in an outpatient population of 1320 patients. Gosselin 
et al.
14
 examined a population of 625 outpatients in 1998 and found an incidental rate of  
 
Figure 5  Segmental embolus in a patient known to have lung cancer.  
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PE of 0.6%. Both these studies were performed using single-detector systems with 
relatively large collimation (5–10 mm). More recently in 2005, Storto et al.
3
 reported an 
incidence of 0.9% unsuspected PEs in 107 outpatient examinations using a four-section 
system. The present study found a higher incidence at 2.2% in an unselected outpatient 
group of 440 and similarly, a study performed recently at our institution by Ritchie et al.
2
 
reported an incidence of 5.7% of unsuspected PEs in inpatients. Both these recent studies 
used mostly 16-section MDCT, and a high proportion of the unexpected emboli were at 
the segmental or sub-segemental level. The higher rate of detection of PE in recent 





 and the ability to identify small peripheral emboli that were 
not previously seen using single-section systems.
17-21,
  
In the present study, the majority of PEs were positively identified at the time of the initial 
report, but three of the 10 positives were initially missed, which is a similar finding to the 
previous study.
2
 It is possible that suboptimal window settings could have contributed to 
failure to identify these emboli. In a study of 581 patients, Storto et al.
3
 concluded that the 
use of wide window settings improved the detection of PEs. It is also possible that the size 
of the emboli resulted in their being overlooked (all were sub-segmental). 
In conclusion, an unsuspected PE was found in 2.2% of the unselected outpatient 
population undergoing MDCT examinations of the thorax. This is a higher proportion 
than has previously been described presumably owing to the use of a 16-section machine. 
Statistical analysis was hampered by small numbers of positive results. There was no 
statistically significant relationship between age and PE. There was also no pattern 
regarding the anatomical distribution of the emboli, although again the numbers of 
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positive examinations were small. These findings suggest that the incidence of PE in the 
outpatient population is higher than previously suspected and unless specifically sought, a 
significant proportion will be overlooked on the initial report. 
This study reaffirms the need for radiologists to be vigilant in the reporting of contrast-
enhanced CT chest and to pay close attention to the pulmonary arteries, even if the 
examination has not been optimally timed for their examination. This study also poses 
questions regarding the management of patients with small asymptomatic peripheral PEs. 
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To describe the anatomical site and laterality of deep-vein thrombosis (DVT) in 
symptomatic patients using contrast venography (CV), and to assess age, sex distribution, 
and accuracy of pre-test clinical suspicion of DVT.  
 
Methods 
One thousand, five hundred and seventy two patients undergoing CV because of clinical 




Thrombi were demonstrated in 511 (32.5%) of all CV studies. Isolated, below-knee 
thrombi were identified in 29.4% of positive studies. There was a left-sided predominance 
of DVT ( ratio 1.24: 1) that was most evident in the elderly and in more proximal veins.  
 
Conclusion 
Almost a third of positive cases were shown to be isolated, below knee thrombi. These are 
thrombi that are more difficult to detect by non-invasive means. A left sided 
predominance of DVT is evident.   
 
Introduction 
Venous ultrasound (US) has replaced contrast venography (CV) as the primary diagnostic 
tool in the investigation of suspected deep venous thrombosis (DVT) in most hospitals.  
Venography is still accorded the status of ‘gold standard’ for imaging DVT,
1,2
 and is more 
sensitive than US in detecting below knee DVT and asymptomatic DVT.  
The main benefits for the use of venous US are its non-invasive nature and lack of 
exposure to ionising radiation.
3,4
  Published data suggests that US studies may miss a 
variable proportion of below knee thrombus with sensitivity for US relative to venography 
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in detecting lower extremity DVT lying between 63% and 100% .
5-8
 The clinical 
importance of below knee DVT is a source of great debate. The main concerns with below 
knee DVT are the short term risk of above knee propagation and the longer term risk of 
post-phlebitic syndrome. Both have associated significant morbidity. With the widespread 
adoption of US, it seems appropriate to define the anatomical distribution of symptomatic 
DVT, with particular reference to the percentage of isolated below knee thrombi relative 
to above knee DVT.  The principal aim of the study was to examine the anatomical 
distribution and laterality of thrombi according to age and gender in a large cohort of 
patients who underwent CV for suspected DVT, thus defining demographic characteristics 
of the cohort.  A secondary aim was to evaluate accuracy of a simple clinical assessment 





 October 1995 and 14
th
 March 2003, 1572 symptomatic patients who 
underwent CV for suspected DVT had clinical and imaging details entered on a venous 
thromboembolism database.  Venography was the principal imaging technique in our 
institution until 2003 when the switch to ultrasound was implemented – virtually no 
venograms are now undertaken.  Currently, around 1100 Doppler venograms are 










Doctors requesting imaging for suspected venous thromboembolism (VTE) were 
requested to complete a short data sheet recording clinical and demographic information.   
Level of pre-test clinical suspicion was also noted. Once radiological investigation had 
been performed, results were recorded by a radiologist and the information collated. Data 
collected included the nature of the study performed, the site investigated and the location 
of any detected thrombus.  Studies were usually carried out by a Specialist Registrar using 
a standard protocol which included screening of the calf veins to ensure all were 
visualised with the films reviewed by a consultant radiologist. Data collection required the 
cooperation of a large number of individuals in different departments and, as is the nature 
with such studies, was incomplete. We have no reason to believe that has biased the study 
in any way. 




Statistical analyses were carried out using the Mann-Whitney U-test, the binomial test and 
chi-square test of association.  A 5% significance level was assumed for all tests and 95% 
confidence intervals were calculated using the Wilson
8
 score method. 





The 1572 patients investigated comprised 676 males (43.0%) and 896 females (57.0%).  
The age range varied between 16 and 99, with a median age at investigation of 65 years.   
The 511 patients (32.5%) who had a positive result consisted of 265 males (51.9% of 
positive cases) and 246 females (48.1% of positive cases).  Males were almost twice as 












































Figure 1 – Age demographics in positive contrast venograms 
 
 
Distribution of thrombi according to age, sex and laterality 
Of the 511 positive cases 15 cases (eight males, seven females) had no data on age 
recorded and were excluded from the analysis of age distribution.  The age at presentation 
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for females (median = 67 years) was significantly higher (p=0.004) than for males 
(median = 62 years). 
In 1396 cases (88.8%) data were available indicating which leg venography was 
performed on. The number of cases for which venography was performed on the left leg 
only, the right leg only and both legs were 694 (49.7%), 565 (40.5%) and 137 (9.8%), 
respectively. A positive CV result for investigation of the left leg only, the right leg only 
and both legs was obtained for 221 (15.8%), 178 (12.8%) and 63 (4.5%).  In cases where 
both legs were examined the laterality of thrombus, whether right, left or indeed both, was 
not recorded.   
 
































































































































The proportion of males and females who had examinations of the left leg only, right leg 
only or both legs proved to be similar (no significant difference, data not shown).  thrombi 
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were identified in 29.4% (150/511) of positive cases and in 9.5% (150/1572) of all 


















































































































Figure 2 – Laterality with increasing proximity of thrombus 
 
Table 1 demonstrates the anatomical distribution of thrombi.  Isolated below knee left 
sided thrombi were more common than right sided thrombi, with a left-to-right ratio of 
1.24:1. (This analysis excluded the 63 patients where both legs were investigated). The 
left-to right-sided ratios for the location categories ‘isolated below knee   thrombus’, 
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‘above knee thrombus not extending to pelvis or IVC’,  ‘above knee thrombus extending 
to pelvis or IVC’ and ‘isolated pelvic or IVC thrombus’ were 0.82:1, 1.43:1, 1.5:1 and 7:1 
respectively (Figure 2). This suggests the detected left sided predominance is evident 
above the knee and becomes more pronounced in more proximal veins.  The odds ratios 
for males versus females of thrombi falling into a particular location category are 1.09 
(95% CI: 0.74, 1.59), 1.16 (95% CI: (0.89, 1.43)), 0.96 (95% CI: (0.39, 1.52)) and 0.26 
































































Figure 3 – Leg Distribution by age in positive contrast venograms 
 
Figure 3 demonstrates that the left sided preponderance is most apparent between 70 and 
79 with a general trend for the effect to be accentuated with increasing age. However left 
sided predominance can also be demonstrated in the 30 to 39 age range.  Neither of these 
differences are statistically significant. 




Association between clinical suspicion and result 
Table 2 compares the level of clinical suspicion with the CV results for DVT for the 1410 
patients for whom data on clinical suspicion were recorded.  The sensitivity and positive 
predictive values of clinical suspicions were calculated with ‘moderate’ and ‘high’ groups 
combined to create a ‘DVT suspected’ group.  Under these circumstances, the sensitivity 
and positive predictive value of clinical suspicion were calculated as 92.1% (95% CI: 
(89.3%, 94.3%)) and 35.5% (95% CI: (32.8%, 38.3%)) respectively. 
Table 2 – Clinical Suspicion 
 
Result of Scan 
Clinical Suspicion 
Positive Negative 
Low 36 185 
Moderate 131 376 
High 291 391 





Venous ultrasonography has superseded contrast venography as the primary test in the 
diagnosis of DVT in the vast majority of centres,
10,11
  although venography is still 
considered the ‘gold standard’ and continues to have a role in DVT imaging, particularly 
in the presence of high clinical suspicion but a negative non-invasive test.
12,13
  Advantages 
of US include rapidity, safety, availability and non-invasiveness.  US has previously been 
associated with a low sensitivity and specificity in detection of below knee thrombosis.  
However, it has been shown that in expert hands ultrasound can have a sensitivity and 
specificity relative to CV 85% to 100% and 85% 





  It is expected that, whilst US is user-dependant, in centres where 
detection rate is nearing 100% then the proportion of below knee DVT detected would be 
approaching the figures that we have reported. It is also acknowledged that contrast 
venography also suffers from a degree of operator dependence and as its use declines that 
its accuracy is also likely to decline.  It must be emphasized that this study was not 
designed to test the accuracy of either technique but was aimed at mapping the site and 
extent of lower limb deep venous thrombosis anatomically in a large symptomatic cohort.  
This is of particular relevance when considering isolated below knee DVT, which may 
remain undetected by US.    Previous work has demonstrated the fact that below knee 
DVT is almost never confined to the anterior tibial veins and has highlighted importance 
of imaging the posterior tibial and peroneal veins.
14, 15
 The actual veins involved when 
below knee DVT was present were not recorded in our study. 
Debate continues to surround the clinical importance of detecting below knee DVT but 
there is no doubt that undetected calf thrombi may unpredictably propagate above the 
knee to give clinically relevant thromboembolism.  Reported rates of propagation of 
below knee DVT vary between 6% and 32%.
16-19
  Detection of below knee DVT may also 




 The threshold for investigation of suspected DVT generally drops following the 
replacement of CV with US as the principle screening tool. With such a change it might 
be expected that there would be more negative studies but also that the proportion of 
patients imaged with isolated below knee DVTs would if anything increase as a less 
symptomatic population associated with a lower investigation threshold would tend to 
have smaller more distal thrombi. A population of patients undergoing Doppler US 
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assessment might be expected to have a roughly similar or possibly slightly higher 
proportion of isolated below knee DVT compared with above knee DVT to that described 
here.  Ultrasound is recognized as being particularly user-dependent with detection rates 
of below knee DVT varying considerably between operators and departments.  Using 
these CV figures as a ’gold standard’ departments and individuals will be able to 
extrapolate roughly how many, if any, below knee DVTs they are missing. These are 
particularly likely to be missed if the simple 3 point compression test is used.
22
 
In the present study, although more venograms were carried out on females, our finding of 
roughly equal overall numbers of positive examinations in both sexes corresponds with 
other studies.
23
  It may be that the possibility and thus investigation of DVT is more 
readily considered in women, perhaps due to greater awareness of risk factors such as the 
oral contraceptive pill, pregnancy or hormone replacement therapy
24
, or they may be more 
prone to leg swelling for other reasons.   
Increasing prevalence of DVT with increasing age (as illustrated in Figure 1) is well 
recognised
25-27
. This can be accounted for by the accumulation of known risk factors with 
increasing age for VTE, such as immobility and malignancy. 
28-30
 Longer female life 
expectancy is likely to explain the predominance of positive female cases above the age of 
70 and also the significant difference in the median age of presentation. 
Sex did not significantly influence the regional distribution of thrombi, though there was a 
trend for males to have more thrombus below the inguinal region and for females to have 
greater rates of thrombus confined to the pelvis or IVC.  The number of isolated pelvic 
and IVC DVT in our series was very small (<3%), but these thrombi can also be missed 
by US. 
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The increased incidence of DVT in the left as opposed to right leg has been recognised
31
.  
However, there are two additional features of this left-sided predominance highlighted 
here; its tendency to be particularly marked in more proximal regions and its apparent 
augmentation in elderly patients (Figure 3).  The difference between legs in more elderly 
groups may be partially attributed to the May-Thurner effect, where left iliac vein external 
compression is associated with a higher rate of venous thrombosis in left sided veins.
32,33
   
We postulate that the increase in left-sided DVT in elderly patients above the age of 60 
may be due to augmentation of the May-Thurner effect caused by atheromatous dilatation, 
tortuosity and reduced compliance of the iliac arteries. 
 
The May-Thurner effect may also be responsible for the increased ratio of thrombi in the 
left side veins proximally. Thrombi usually originate from the calf in the venous sinuses 
or the valve cusp pockets, and some of these propagate above the knee.
34-36
 It may be the 
rate of development of calf DVT distally is similar in both legs but because of the May-
Thurner effect and the venous stasis associated with it, after development of a thrombus it 
is more likely to propagate on the left with that tendency increasing the more proximally 
the thrombus extends.  
It is reassuring to see that the increasing clinical suspicion of DVT was associated with 
greater rates of radiologically proven DVT.  However, even among patients with a high 
clinical suspicion of DVT, 57.3% of investigations were negative.  This supports the 
adoption of a standardised scoring system for grading the suspected severity of DVT in 
order to improve the pre-test predictive value.
37
 
In conclusion, in this large prospective series of patients undergoing CV for suspected 
VTE, 29.4% of positive patients had isolated below knee DVT,with the high proportion of 
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isolated below knee DVT demonstrated providing a useful baseline for US-based studies 
of DVT distribution.  A left- sided predominance was evident between 30 and 39 and 70 
and 79 and more pronounced with more proximal DVT, whilst a moderate or even high 
clinical suspicion of DVT is a poor positive predictor for thrombi, reinforcing the 
requirement for more robust methods for establishing the likelihood of DVT. 
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We conducted a nationwide, retrospective cohort study assessing the risk of cancer in 
VTE patients diagnosed in Scotland 1982-2000. 
Significantly elevated risks of cancer were sustained for two years after VTE diagnosis; 
most notably for ovarian tumours and lymphomas.  Younger patients were at an increased 
relative risk from this association.   
 
Introduction 
Trousseau (1872) observed the association between thrombotic phenomena and cancer as 
far back in 1865. Since then numerous studies have documented the increased risk of 
cancer patients developing DVT and PE. More recently association has been made 
between initial presentation with venous thromboembolism (VTE) and subsequent 
increased risk of cancer. This association has been investigated in several studies but 
conclusions vary widely from no excess risk (Griffin et al, 1987:
 
O’Connor et al 1984)
 
, to 
a definite increased risk (Golgberg et al 1987: Prandoni et al 1992: Sorensen et al 1998: 
Baron et al 1998)
  
.  Results of the time span of increased risk after DVT/PE diagnosis also 
vary, as do the types of cancer involved and the age groups that are at highest risk. This 
study was designed to determine 1) if there is an increased incidence of cancer in a large 
population-based cohort of Scottish patients with a new diagnosis of VTE, 2) to 
investigate any excess risk in relation to time since, and age at diagnosis of VTE and 3) to 
identify which cancers, in a Scottish population, are particularly associated with previous 
VTE.   
 




Materials and Methods 
Patients. 
The Information and Statistics Division (ISD) of the National Health Service (NHS) in 
Scotland has linked (at time of analysis), using probability matching, information on all 
Scottish hospital inpatient discharges (1981-July 2002), death records (1981-2002), and 
cancer registry records (1981-2000). For this study all records for patients diagnosed with 
a DVT (ICD 9 451.1 and ICD10 I26, I80.1, I80.2), or PE (ICD9 415.1 and ICD 10 I26) 
between 1982 and 2000 were selected from the linked database giving a population based 
database covering 19 years. Individuals presumed to be visitors who did not have a 
Scottish postcode and for whom follow-up data would not be available were excluded. To 
reduce the number of patients with secondary VTE, patients who had undergone surgery 
in the 6 weeks prior to VTE were excluded, as were pregnant females. Due to the 
difficulties in coding we were unable to exclude those with haemostatic defects 
(thrombophilia). Follow-up for the occurrence of cancer was from the initial diagnosis of 
DVT/PE until the end of 2000 because the cancer records were not complete beyond this 
point. Hospital inpatient discharge data was available from 1981 onwards; however, the 
starting date was restricted to 1982 to reduce the erroneous inclusion of cases that had 
recurrent VTE. 
  Cancer diagnosis following DVT/PE was included if it was a first diagnosis of 
malignant cancer.  Patients with a previous primary malignant cancer were excluded from 
the study.  Only first cancers were included to avoid cancer itself being a confounding 
factor for a subsequent cancer, through genetic susceptibility, shared risk factors, or the 
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effects of therapy. Data for non-melanoma skin cancer was excluded, as data is less likely 
to be complete for this common and usually non-fatal condition that often does not require 




The expected number of cases of cancer in the cohort of VTE patients was calculated on 
the basis of Scottish national incidence rates of first malignant cancer according to age (5 
year age bands to 85+), sex and  period of diagnosis (1982-86, 1987-91, 1992-96, 1997-
2000).  Multiplying the number of person years of observation accumulated by the cohort 
(calculated from the date of diagnosis of VTE to the date of cancer diagnosis, date of 
death, or 31/12/2000, whichever came first) by the national incidence rates (by age, sex 
and time period) yielded the expected number of cancers of the VTE cohort if they were 
exposed to the same risk as the general population, calculating person-years for each 
subgroup (age at VTE diagnosis and time since VTE diagnosis) separately.  The ratio of 
observed to expected cases gives the standardised incidence ratio (SIR) or relative risk, 




In total 77,572 patients were identified with DVT/PE or both diagnosed between 1981 and 
2000.  After applying the exclusion criteria our cohort contained 59,534 patients, of whom 
55% were female and 45% male. In all  11.1% were ≤39, 21.2% were 40-59, 22.4% 60-
69, 26.7% 60-79 and 18.7% 80+.    The median duration of follow-up was 32 months.  
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Overall Risk of Developing Cancer 
Over the 19 -year period 4,441 (7.5%) patients were diagnosed with a first primary cancer 
after (at least 1 month after) their VTE diagnosis.  The standardised incidence rate (SIR) 
for all cancers was 1.28 (CI 1.25-1.33) compared to that expected based on the incidence 
of first malignancies in Scotland.   
Table 1: Observed and Standardised Incidence Ratios (SIR) of First Cancers 




Risk of cancer in relation to time since, and age at diagnosis of VTE 
For all malignancies combined there was a high excess risk of being diagnosed with 
cancer (SIR 4.2, CI 3.9-4.5) within 1 to 6 months after diagnosis of VTE; with a slowly 
declining but still significant excess risks for each six-month follow-up period up to two 
Insights into VTE                                        John T Murchison                                                      
 
 132 
years.  The risk was significantly raised for all individual malignancies calculated, but of 




Table 2 Standardised Incidence Ratios (SIR) with 95% confidence intervals of 
First Cancers Diagnosed among Patients with previous VTE assessed according 
to age band and time interval after diagnosis of VTE. 
 
and Non-Hodgkins lymphoma (Table 1).  The risk after 2 years was very similar to that 
expected in the general population. This excess risk within the first two years was seen in 
all age groups but declined as age increased (table 2) with excess risk approximately twice 
as large in patients aged under 60 at VTE diagnosis compared to those aged 60 or over 
(table 2) .  
 
Discussion 
We evaluated the association between VTE and subsequent diagnosis of cancer in a 
large cohort and demonstrated a definite increased risk of being diagnosed with 
malignancy after a primary episode of VTE. The risk is particularly marked within 1 to 12 
months after VTE diagnosis. Some studies have suggested that a small increase in risk 
persists many years after the diagnosis of VTE (Golgberg et al 1987: Prandoni et al 1992). 
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Our overall figures show an excess risk sustained for the first 2 years after VTE diagnosis, 
and thereafter, the risk returns to that expected based on background rates.  In our cohort 
the excess risk of cancer was highest in patients aged under 60 at VTE diagnosis,  
however, as malignancy has an increased prevalence with increasing age, older patients 
have a greater absolute risk of malignancy after a first episode of VTE with one in twenty-
five 60-75 year olds developing cancer within one year (fig1). The results of this study 
can only be generalised to patients admitted to hospital, and relies on accurate discharge 
coding, cancer registration and linkage. As almost all acute illnesses are treated in NHS 
hospitals in Scotland and as over the period of the study the practice was to admit acute 
VTE to hospital for stabilisation of anticoagulation it is likely that most diagnosed cases 
have been included. There may however be other undiagnosed cases that we are unaware 
of as VTE is a diagnosis which is difficult to make clinically and which is often 
overlooked. The accuracy of discharge coding data in Scotland is estimated at around 
90% (Harley et al 1996) and the quality of cancer registry data is also high (Brewster et al 
1994: Brewster et al 1997). Mismatched records in the Scottish record linkage system 
occur in less than 2% of cases (Kenrick and Clarke 1993). Any bias introduced by mis-
coding or mismatched records is likely to underestimate risk. Bias occurring due to loss of 
subjects through migration is likely to be small and would also lead to an underestimation 
of risk. 
 Although our analysis had the strength of being a large population-based study, our 
data lacked clinical detail, in particular about risk factors for thromboembolism and the 
stage of the cancer at diagnosis.   
 




Figure 1 Percentage of patients who developed cancer within 1–12 months after 
the first episode of VTE in relation to the total number of VTE patients, by age at 
VTE diagnosis. 
 
This study provides further evidence for the increased  risk of developing cancer after 
an episode of primary VTE and shows this persists for a 2 year period, however, it does 
not provide an answer to the question whether such patients should be screened for occult 
malignancy. It is reported that in cases where cancer is diagnosed after an episode of VTE 
the cancer is often advanced and the outcome is very poor with a one-year survival of 
only 12% (Sorenson et al 2000). It is also uncertain whether earlier diagnosis changes 
outcome, and any perceived benefits of earlier diagnosis must be weighed against the 
psychological and physical morbidity and discomfort associated with extensive 
investigations (Nordstrom et al 1994: Prins et al 1994). Simple clinical and diagnostic 
methods of screening, in patients with idiopathic DVT/PE seem sensible and are 
recommended in other studies (Monreal et al 1991: Sorensen et al 2000: Piccioli et al 
1996).  
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The influence of weather on deep venous thrombosis (DVT) incidence remains 
controversial. We aimed to characterise the temporal association between DVT and 
meteorological variables including atmospheric pressure. Data relating to hospital 
admissions with DVT in Scotland were collected retrospectively for a 20 year period for 
which corresponding meteorological recordings were available. Weather variables were 
calculated as weighed daily averages to adjust for variations in population density. 
Seasonal variation in DVT and short-term effects of weather variables on the relative risk 
of developing DVT were assessed using Poisson regression modelling. The model 
allowed for the identification of lag periods between variation in the weather and DVT 
presentation. A total of 37.336 cases of DVT were recorded. There was significant 
seasonal variation in DVT with winter peak. Seasonal variation in wind speed and 
temperature were significantly associated with seasonal variation in DVT. When studying 
more immediate meteorological influences, low atmospheric pressure, high wind speed 
and high rainfall were significantly associated with an increased risk of DVT 
approximately 9-11 days later. The effect was most strikingly demonstrated with 
atmospheric pressure, every 10 millibars decrease in pressure being associated with a 
2.1% increase in relative risk of DVT. DVT is particularly associated with reduction in 
atmospheric pressure giving weight to the hypothesis that reduced cabin pressure in long 
haul flights contributes to DVT. These findings have implications for our understanding 
of the pathogenesis of DVT.    
 







In the US venous thromboembolism (VTE) has an estimated incidence exceeding 1 per 
1000 of the population, contributing to over 50,000 deaths per annum.
1
 While a number of 
well defined risk factors for the development of VTE are recognised (such as immobility, 
recent surgery, recent fracture, pregnancy, malignancy and oestrogen therapy) the 
influence of meteorological variables remains controversial.  
 
Pulmonary embolism (PE) has been associated with low atmospheric pressure, low 
temperature, high rainfall, high relative humidity and high vapour pressure.
2-6
 The effects 
of meteorological variables on deep vein thrombosis (DVT) are less well characterized. 
Overall, the emergence of a consistent effect of weather on VTE has been hampered by 
the requirement for large datasets to detect relatively small influences on the risk of VTE, 
and a tendency for previous, smaller studies to yield conflicting conclusions.  
 
Scotland is a comparatively small country both geographically and demographically 
(population approximately 5.1 million), with a relatively stable population, well-
established meteorological records and a centralized diagnostic coding system for hospital 
admissions. This combination presented us with the opportunity to make a detailed 
assessment of the associations between DVT and variations in weather. The aim of this 
study was therefore to investigate the temporal association between DVT and 
meteorological variables, with particular emphasis on atmospheric pressure.  







Data on all discharges from Scottish hospitals, covering the country’s entire population, 
are compiled at the Information Services Division (ISD), National Health Service (NHS) 
Scotland. Diagnoses are recorded on each patient’s hospital discharge summary using 
standard International Classification of Disease (ICD) codes. All acute presentations to 
hospital with a diagnosis of DVT over the period 1
st
 January 1981 to 31
st
 May 2001 were 
included in the study. Patients were considered to have had DVT if the principal diagnosis 
recorded was ICD9 (4511 or 4151) or ICD10 (I80). The index date for each patient was 
taken to be the date of admission to hospital. 
 
 Data from weather stations in each of the fifteen NHS Trusts in Scotland were recorded 
each day during the corresponding period and provided by the National Meteorological 
Office. Measured variables included atmospheric pressure, temperature (minimum and 
maximum), hours of sunshine, rainfall, snowfall and wind speed. Atmospheric pressure 
and wind speed were calculated as the average of four 6 hourly readings taken each day. 
Average daily weather statistics for the whole of Scotland were calculated as weighted 
daily averages of the values recorded at the 15 weather stations, with weights taken as the 
population sizes of the NHS Trusts. This ensured that weather statistics most closely 
matched the population covered.  
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To test for seasonal variation in the rate of DVT, the number of DVTs per calendar month 
was calculated, and a Poisson regression model was used to determine whether the 
months differed significantly.  
On the assumption that weather may affect the incidence of DVTs through seasonal 
effects and/or short-term changes, models were constructed to incorporate these 
influences. To assess the seasonal influence, average weather statistics and numbers of 
DVTs were calculated for each week of the year (ie 1,2,3,…,52) and Spearman rank 
correlation coefficients calculated to assess the correlations between them. To assess the 
short term effects of weather, daily meteorological statistics and numbers of DVTs were 
analysed using Poisson regression models. These models adjusted for day of the week, 
seasonal trend (by fitting week of the year), time trend (to allow for the increasing 
incidence of DVT observed throughout the study period) and change in diagnosis rates 
following the switch from ICD9 to ICD10 coding in April 1997.  On the assumption that 
there would be a delay between any biological influence of meteorological variables and 
clinical presentation with DVT, models included lag periods for the effect of weather 
varying from 0 to 21 days prior to presentation. 
 
RESULTS 
A total of 37336 cases of DVT were recorded in the study period. The mean age of the 
patients was 60.8 (SD 17.6) years and 48.0% were male. There was a significant seasonal 
variation in the incidence of DVT, with the highest average incidence in January and the 
lowest in August (p<0.0001; Figure 1). Meteorological data for the study period are 
described in Table 1 and all measured weather variables had a highly significant seasonal 
variation (p<0.0001). The seasonal variation in DVT was significantly associated with the 
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seasonal variation in wind speed (p=0.006), minimum and maximum temperature 
(p=0.0009 and 0.001 respectively), and snowfall (p=0.01), but not with atmospheric 
pressure, rainfall or hours of sunshine. 
 
 
Figure 1: Seasonal variation in DVT rate. Result represents the mean daily rate 
(%) of DVT in each calendar month ( error bars represent 95% confidence 
intervals.) 
 
When considering short-term influences of weather, low atmospheric pressure, high wind 
speed and high rainfall were associated with significantly increased rates of DVT (Table 
2). The association was most striking for atmospheric pressure (Figure 2). For each 
variable the association was characterized by a lag period, typically of the order of 9-10 
days. The data suggest that a relative decrease in atmospheric pressure results in an 
increased risk of presenting with DVT some 6 to 12 days later. The risk was greatest for a 
lag period of 9 days with the relative rate of DVT increased by 2.06% (95% CI 1.14-
2.99%) per 10 millibars decrease in pressure. Similarly an increased wind speed was 
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associated with a significantly increased rate of presenting with DVT 9 to 12 days later, 
the greatest increase being identified for a lag period of 10 days. An increase in rainfall is 
associated with a significantly increased rate of presenting with DVT 2, 10,11 and 13 days 
later, the relative rate being greatest for a lag period of 10 days. High snowfall on the date 
of admission was associated with a reduction in the rate of presenting with DVT. No clear 
association was found between the incidence of DVT and the short term effect of 
temperature or hours of sunshine. 
Table 1: Mean daily values for measured meteorological variables by calendar month 
 
DISCUSSION 
The study benefits from the large number of patients accumulated using a consistent 
national system for recording health outcome data throughout Scotland over a 20 year 
period.  As a small country (approximately 79000 km
2
) with a temperate climate 
influenced largely by the Atlantic Gulf Stream, widely ranging extremes of weather in 
different locations on the same day are relatively unlikely.   
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It is recognised by physicians and radiologists involved in the diagnosis and management 
of venous thrombo-embolism that, although a common disease, the numbers of patients 
presenting with the disease varies greatly from week to week and month to month.   
Table 2:Short-term effects of weather on incidence of DVT’s, adjusted for seasonality. Results are 
expressed as percentage relative rate. *Statistically significant alterations in rate at the p<0.01 
level. Thus, for example, for every 10 millibars fall in pressure on a given day, the relative rate of 
DVT 9 days later is increased 2.06%, the relative rate 10 days later is increased by 1.85% etc. 
 
Our findings suggest that meteorological factors may contribute to this variability 
describing a seasonal variation in the incidence of DVT, with winter predominance.  They 
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also suggest that low atmospheric pressure, high rainfall and high wind speed are 
associated with a small but significantly increased rate of DVT with a distinct lag period 
(typically 9-12 days) characterizing the relationship between these variables and 
subsequent presentation with DVT. Small calf DVT are often initially asymptomatic and 
it is recognised that is often a lag time between insult the initial insult where DVT first 
develops and the time of clinical presentation and diagnosis at hospital. The finding of a 
significant correlation between a drop in atmospheric pressure and presentation with DVT 
puts that delay at maximum between days 6 and 12. High rainfall 2 days prior to 
presentation was also statistically significant in predicting DVT, however the biological 
significance is unclear as high rainfall for lag periods of 1 and 3 days was not significant. 
 
Various studies have addressed the question of seasonal variation in VTE. A large 
retrospective study involving 65000 cases of DVT and over 60000 cases of PE in France 
found clear evidence for seasonal variation,
7
 broadly in keeping with smaller studies from 
Europe and Australia.
3,8-12
 This effect appears to extend beyond idiopathic DVT, having 
also been described for post-operative DVT.
13
 Importantly, in studies reporting a seasonal 
variation the trend for a winter and autumn predominance has been relatively consistent. It 
must be emphasized that seasonal variation has not been observed by all investigators,
14-17
 
however it may be relevant that the two largest studies to date (our own study and that by 
Boulay et al,
7
) found a trend towards winter predominance. 
 
Many biological variables could potentially contribute to the seasonal influence on VTE. 
For example a procoagulant profile is known to develop in venous blood during colder 
months.
18
 In addition respiratory infections are commoner in winter months and are 
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themselves associated with an increase in VTE.
19
 Furthermore, it may be plausible to 
argue that populations are more sedentary during the winter.  
 
Our finding that low atmospheric pressure is associated with DVT is broadly in keeping 
with previous observations in VTE. In particular Esquenet et al
20
  found an association 
between DVT and low atmospheric pressure which was more pronounced as pressure 
gradients widened. In an earlier study Scott et al
4
 found that PE was associated with a 
decrease in atmospheric pressure.  Importantly, they also found a lag effect but this was of 
the order of 3 days as opposed to the longer interval described here. A Turkish study 





In contrast, studies by Becker et al
2
 and Clauss et al
5
 failed to demonstrate an association 
between atmospheric pressure (or temperature) and PE. Interestingly however these 
studies, both of which were smaller than the present study, identified a relationship 
between PE and high rainfall in keeping with our own observations.  
The emerging picture for VTE finds some parallels in studies of arterial thrombosis.
 21
 For 
example myocardial infarction has variously been associated with increased incidence in 
the winter months, low temperature, and low/falling atmospheric pressure.
22-24
    
 
Our analyses of short term weather effects (Table 2) were adjusted for seasonality and 
therefore the association found between meteorological variables and DVT is not an 
epiphenomenon based on seasonality. This in turn begs the question of how influential 
atmospheric pressure, rainfall and wind speed are in the development of DVT. Our data 
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suggest that the influence is small but statistically significant. To place this in context a 
relative decrease in atmospheric pressure of 10 millibars predicts for a 2% increase in the 
rate of DVT nine days later (Table 2).  
 
Figure 2: Short-term effects of atmospheric pressure on the rate of presentation with 
DVT. Results are expressed as percentage relative rate for every drop in atmospheric 
pressure of 10 millibars. ( error bars represent 95% confidence intervals.) Any point 
above the broken horizontal line represents an increased rate (and any point below the 
broken line represents a decreased rate) of DVT. Wherever both confidence limits fall 
above ( or below) the line, the difference is statistically significant at the p<0.05 level. 
 
The mean daily variation (SD) in atmospheric pressure in Scotland during the study 
period was 12.8 millibars. Thus on average pressure is predicted to cause DVT incidence 
to rise or fall by 2.6 % each day. Similarly, for every increase in rainfall of 1 mm or for 
every 1 knot increase in wind speed, the rate of DVT 10 days later was increased 0.8% 
and 0.6% respectively, while mean daily variability (SD) in rainfall and wind speed in 
Scotland were 3.4 mm and 3.8 knots respectively. Weather statistics are inter-related, for 
example low pressure often accompanies a period of heavy rainfall. Therefore the effects 
of pressure, wind speed and rainfall on the incidence of DVTs cannot be considered 
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additive. Although statistical models can demonstrate which of the measurements is the 
most predictive statistically, they cannot provide evidence for a causal relationship to 
DVT. However it is tempting to speculate on biological plausibility linking these factors 
to DVT. In this regard it has been shown that hypobaric hypoxia, but not normobaric 
hypoxia, is associated with hypercoagulability in humans,
25-27
 while hypobaric conditions 
favour DVT formation in postoperative rabbits.
28
 Toff et al
29
 did not show a statistical 
increase in hypercoagulability in relation to hypobaric oxygen in a group of patients 
without known thrombophilia. However their exploratory analysis did show greater 
dispersion with more outliers in the distribution of changes in coagulation activation in the 
hyperbaric than in the normobaric limbs of their study. They accepted that some 
individuals may respond differently and were unable to say whether this finding was due 
to chance or to a genuine biological difference. Our hypothesis is that some, but not all, 
individuals are susceptible to the effects of reduced pressure and that those who are 
susceptible are more likely to be those with a pre-existing thrombotic tendency. In the 
background, a vigorous debate continues to surround the effect of flying on VTE.
30-35
 The 
cabins of commercial aircraft are generally pressurised to a level equivalent to 8000 feet 
above sea level (700 millibars), and have relatively low humidity. Evidence for a small 
increase in the rate of DVT on particularly long flights seems to be emerging and it could 
be speculated that our data broadly support reduced air pressure as a plausible 
contributing factor towards the development of DVT in long haul flights in susceptible 
individuals. 
 
The effects of rainfall and wind speed on DVT have not received much scientific 
attention. It has been postulated that pro-thrombotic pollutants could be carried as 
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condensation nuclei in water droplets.
5
 This contention could be extended to encompass 
increased dispersal of atmospheric pollutants and/or organic/infective particles by 
increased wind speeds. However this remains entirely conjectural and has not been 
scientifically tested. Alternatively the relationship with rainfall and wind speed may have 
arisen purely as a consequence of their association with atmospheric pressure. 
 
Several potential limitations of this study should be acknowledged, particularly the 
retrospective design. This raises concerns especially over accuracy of diagnosis of DVT, 
and the potential for missed cases. Available evidence suggests that over the duration of 
the study hospital-based diagnosis of DVT in Scotland was increasingly based on 
objective investigations rather than clinical assessment alone
36,37
 and diagnostic 
confirmation is therefore likely to have been high. It is also reassuring that the incidence 
of DVT over the 20 year study period (approximately 30 per 100,000 per annum) is 
broadly in line with other incidence estimations.
1
 However, any inconsistencies in 
diagnosis are unlikely to alter the seasonal and short term associations demonstrated. 
Also, multiple tests of significance have been carried out to assess the different weather 
statistics and lag periods and caution is needed when interpreting significance levels. 
However, the overall pattern of results across the lag periods helps to confirm the 
presence of a genuine effect.
38
 For example, the effect of atmospheric pressure is 
negligible on the day of presentation, significant during days 6-12 reaching a peak at 9 
days and then negligible again by 21 days.  
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In summary low atmospheric pressure, high rainfall and high wind speed are associated 
with a small but significant increase in the rate of DVT. The mechanisms and interactions 
involved deserve further scientific attention. 
Source of Funding. 
 
£2000 was paid by the University of Edinburgh towards the cost of statistical analysis for 
this study. 
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 We carried out a retrospective study of prognosis in Scottish patients diagnosed with 
cancer within five years following a venous thromboembolism (VTE).  
 
Results and Conclusions 
Prognosis was significantly poorer if a VTE occurred up to two years before  cancer 




Trousseau first described an association between malignancy and venous 
thromboembolism (VTE) more than a hundred years ago (Trousseau 1872), since which 
time it has become clear that malignancy is a risk factor for VTE.  More recently, several 
large retrospective population studies have shown an increased risk of cancer after a 
diagnosis of  idiopathic VTE with standardised incidence ratios of 3 - 4.2 within the first 
six months.
1-3 
  The length of time for which increased risk can be shown varies and we 
have previously shown a persistent, albeit declining, risk up to two years from VTE 
diagnosis.
3 
Those with secondary VTE do not seem to be at similar risk of future 
malignancy.
4-5
 In view of this increased risk, there has been an interest in screening 
patients with idiopathic VTE for occult malignancy.  Initial retrospective studies in 
patients with idiopathic deep vein thrombosis (DVT) suggested that most occult 
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malignancy could be detected at presentation by routine evaluation.
1,6
 However, more 
recent prospective studies advocate a more intensive investigative approach
7-8 
. 
Relatively little is known about the impact that a preceding VTE has on the prognosis of 
subsequent malignancy and this may well inform the screening debate.  A Danish registry 
study compared survival in patients with cancer and a preceding history of idiopathic VTE 
with that of a matched control group of cancer patients without preceding VTE.  Those 
diagnosed with cancer during their admission for VTE had a one year survival of 12% 
compared to 36% in the control group.  One year survival rates were also poorer in those 
diagnosed with cancer in the year following a VTE.
 9
 
Following on from previous work, we conducted a retrospective study examining the 
prognosis of Scottish patients in whom malignancy was diagnosed at the time of, or in the 




The Information Services Division (ISD) of the National Health Service in Scotland has 
linked anonymised information (using probability matching) on all Scottish hospital 
inpatient discharges, death records and cancer registry records from 1981 to 2005.  For 
this study, all records with a diagnosis of DVT or pulmonary embolism (PE) between 
1982 and 2000 were selected from the linked, non-identifiable database, giving a 
population-based database covering 19 years.   
To reduce the number of patients with secondary VTE, those who had undergone surgery 
in the preceding six weeks were excluded, as were pregnant females.  Due to difficulties 
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in coding, we were unable to exclude those with thrombophilias.  Records without a 
Scottish postcode were excluded  
 
Cancers were classified as occurring following a VTE if they represented a first diagnosis 
of malignancy, excluding non-melanomatous skin cancers, in the five years following a 
VTE. 
 Table 1: Numbers available for analysis according to cancer site and time period 




ICD= International Classification of Disease; VTE = venous thromboembolism. .. &All 
malignancies within the range ICD 10 C00-C96 excluding non-melanomatous skin cancer 
 
Patients with a previous diagnosis of malignancy were excluded to avoid cancer itself 
being a confounding factor for subsequent malignancy.  Cancer registrations derived 
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solely from death certificates were excluded due to lack of survival information.  Follow-
up for the occurrence of cancer was from the initial diagnosis of VTE until the end of 
2000, allowing five year survival analysis of all cancer patients following diagnosis up to 
the end of 2005. 
Kaplan-Meier survival analysis was used to obtain estimates of crude survival at one and 
five years following cancer diagnosis, by cancer site and timing of VTE.  Multivariate 
Cox’s proportional hazard models
10
 were used to assess the impact of VTE on survival for 
each cancer site separately.  Adjustment was made for age (<50, 50-59, 60-69, 70-79, 80+ 
years), sex, period of diagnosis (1986-90, 1991-95, 1996-2000) and deprivation decile
11
. 
Patients without a VTE in the five year prior to malignancy served as the reference group 




We identified 4322 patients diagnosed with VTE who were then diagnosed with a first 
malignancy in the subsequent five years.  The 299 714 patients diagnosed with 
malignancy in the same time period, but who had not been diagnosed with a VTE in the 
preceding five years served as the reference group.  The breakdown of these figures by 
cancer site and timing of cancer diagnosis is given in Table 1. Amongst those with VTE 
and malignancy, the commonest cancer sites were lung, colon, prostate and breast 
reflecting the most common cancer sites overall.   Patients with a VTE up to two years 
before a diagnosis of malignancy was made  had a poorer prognosis than those without a 
preceding VTE as detailed in Table 2. Across all the cancer sites examined and in the 
group as a whole, the prognosis was particularly poor if the VTE occurred at the time of, 
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or in the six months prior to, diagnosis of malignancy with a hazard ratio (HR) of 2.48 
(p<0.001) for all cancers combined.  Within this group, malignancies of the cervix, uterus, 
pancreas, rectum and breast  had the poorest prognosis comparatively with hazard ratios 
greater than 2.5.  For all cancers combined, the hazard ratios remained elevated at 1.21 
(p= 0.002) and 1.26 (p<0.001) respectively for those with a VTE 6-12 months and 1-2 




This study examined the survival of over 4000 patients diagnosed with cancer at the same 
time as, or in the five years after a diagnosis of VTE and compared it to cancer patients 
who did not have VTE at presentation or in the preceding five years.  Those diagnosed 
with cancer 0-6 months after a diagnosis of VTE have a significantly poorer prognosis, 
and this remains so for patients diagnosed with VTE up to two years before cancer 
diagnosis.  The crude one-year survival for all cancers combined was 19% for those 
diagnosed at the time of, or in the six months following, a Cancers were classified as 
occurring following a VTE if they represented a first diagnosis of malignancy, excluding 
non-melanomatous skin cancers, in the five years following a VTE.  This compares to a 
54% one-year survival for all cancers in the reference group (data not shown). Our 
findings are in keeping with those of earlier work showing a mortality ratio of 2.46 at one 
year if VTE and cancer were diagnosed concurrently
 9
  
A limitation of our study is the lack of staging data which. ISD only began collecting 
staging data for a limited number if cancers in 1997 and which were  insufficient  for 
analysis.   
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Table 2 Multivariate hazard ratios according to time period for each cancer site. 
 
ICD= International Classification of Disease; VTE = venous thromboembolism. . Results 
quoted are hazard ratios with 95% lower and upper confidence intervals in brackets. 
†Indicates a P-value of < 0.001. *Indicates a P value of <,0.05. &All malignancies within 
the range ICD 10 C00-C96 excluding non-melanomatous skin cancer. 
 
Therefore, we cannot comment on the prevalence of metastatic disease at presentation, 
and the poor prognosis seen in those with VTE at presentation or in the preceding six 
months, may reflect a later stage at diagnosis.  Sorensen et al did not match for stage, but 
did have staging data.  They found a prevalence ratio of 1.26 for metastases in those 
diagnosed with VTE and malignancy concurrently as compared with controls.
12
 It is 
therefore likely that the extent of cancer spread at presentation, as measured by traditional 
staging methods, does not fully explain the poorer prognosis of these patients.  
Morbidity and mortality directly arising from the VTE itself are unlikely to be solely 
responsible, particularly as the prognosis remains poor for malignancies diagnosed up to 
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two years after the thromboembolic event.  A complex interaction between coagulation 
cascades and tumour cell biology exists and there is a growing understanding of the 
potential role of coagulation pathways in modulating tumour growth.
13-15
  
However it is not clear whether hypercoagulability itself predisposes to a more aggressive 
cancer or whether hypercoagulability is simply an early manifestation of such a disease.  
The former possibility suggests a potential for modulating tumour growth using agents 
acting upon the coagulation cascade.  
This is a retrospective study and as such relies on the accuracy of the databases.  The 
accuracy of discharge coding in Scotland is estimated at around 90%.
16
  The quality of 
cancer registry data is also high
17
 (with mismatches in the linkage system occurring in less 
that 2% of cases.
18 
 
This study provides evidence that, for all cancers combined, a diagnosis of VTE in the 
two years before cancer diagnosis is associated with a poorer prognosis, particularly if 
VTE is diagnosed concurrently or in the six months before cancer diagnosis. In view of 
the poor prognosis experienced by these patients, extensive investigation for underlying 
malignancy may not yield a survival benefit and additional studies are needed to clarify 
this. Further work is required into the mechanisms behind this association and the 
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To determine the correlation between increasing pulmonary embolism thrombus load and 
right ventricular dilatation as demonstrated by CTPA and to assess the thrombus load 
threshold which indicates impending right ventricular decompensation. 
 
Methods:  
2425 consecutive CTPAs were retrospectively analysed. Thrombus load using a modified 
Miller score (MMS), RV: LV ratio, presence of septal shift, pulmonary artery and aortic 
size were analysed in 504 positive CTPA scans and a representative cohort of 100 
negative scans. Results were correlated using non-parametric analysis (two-tailed or chi-
squared test) and Pearsons rank correlation.  
 
Results: 
Increasing thrombus load correlated with higher RV: LV ratio with statistically significant 
difference in RV: LV ratios between the negative and positive PE cohorts. Larger 
thrombus loads (MMS ≥ 12 vs. <12) were strongly correlated with right ventricular strain 
(mean RV: LV ratio 1.323 vs. 0.930, p <0.0001). Smaller thrombus loads had no 
significant influence on RV strain. Septal shift was also more likely with a MMS ≥12, as 








With increasing thrombus load in PE, there is CTPA evidence of right ventricular 
decompensation with a MMS threshold of 12. This suggest a ‘tipping point’ beyond 
which right ventricular decompensation is more likely to occur. 
 
Advances in knowledge: 
This is the first study to describe this ‘tipping point’ between thrombus load above MMS 
12 and an increase in RV: LV ratio. This finding may help improve risk stratification in 
patients with acute pulmonary embolism diagnosed by CTPA.  
 
Introduction: 
Acute pulmonary embolism (PE) remains a diagnostic challenge for physicians and 
accounts for significant morbidity and mortality in hospitalised patients. In the UK, the 
incidence of proven PE is 60-70 per 100,000 population and mortality rates range from 6-
15%.  Clinical manifestations vary widely from asymptomatic patients with small 
peripheral emboli to patients who present with circulatory collapse who have large 
thromboembolic loads who may warrant thrombolysis. Between these extremes, there is a 
significant group who present with PE in whom there is apparent clinical haemodynamic 
stability but there are radiological findings (e.g. echocardiography, CT pulmonary 
angiography) or biomarkers (such as BNP or troponin) of right heart strain in whom the 
prognosis may be poorer and for whom the role of thrombolysis has not been established 
[1-4]. Studies to date have demonstrated that right heart strain is associated with higher 
mortality than those with no right heart strain [5,6] and CT assessment of the right heart 
strain correlates with echocardiographic findings [7]. 




CT pulmonary angiography (CTPA) has been established as the imaging modality of 
choice for the initial diagnosis of pulmonary thromboembolism [8, 9] and also confers the 
ability to assess right ventricular afterload [10, 11]. It also readily allows quantification of 
thrombus load for which a variety of methods are available. These include the modified 
Miller Score (MMS), a catheter pulmonary angiography score [12] adapted for CTPA by 
Bankier et al. [13]
 




The aim of this study was to determine if there was a correlation between increasing 
thrombus load using MMS and right ventricular dilatation as a predictor of right 
ventricular failure according to CTPA findings. 
 
Methods 
The reports of 2425 consecutive CTPA scans undertaken over a 40 month period from 
2001 to 2004 at the Royal Infirmary of Edinburgh (RIE), Scotland, UK were 
retrospectively reviewed. All CTPA scans reported positive for the presence of PE were 
included in the study and the Modified Miller Score and right and left ventricular 
dimensions were calculated.   
To act as a comparison group we included scans in 100 consecutive patients in whom PE 
was suspected but subsequently refuted by CTPA imaging. A 100 matched controls was 
calculated to be sufficiently powered, based on the mean RV: LV ratio of 1.087 in this PE 
cohort (SD 0.412), to achieve a true reduction in mean RV: LV ratio of 0.117, using 
power of 80% and a two-sided 0.05 significance level. 





The CTPAs were performed using a multislice CT scanner without cardiac gating on a GE 
Hi-speed Advantage CT scanner, (IG, Milwaukee, WI) using a slice thickness of 3mm 
and a pitch of 1.7:1 with 1.5mm reconstruction from the thoracic inlet to the inferior 
extent of the diaphragm. Approximately 100mLs of intravenous contrast material 
(200mgI/ml) was injected at a rate of 3ml/s.  CTPAs were initially reported by the 
hospital’s diagnostic service. All study scans were independently reviewed by a senior 
radiology specialist registrar with 5 years of CTPA experience and every scan where there 
was discordance in the diagnosis or extent of thrombus was also reviewed by an 
experienced pulmonary radiologist with 16 years of experience of CTPA reporting.  
 
Calculation of Modified Miller Score and Ventricular Dimensions 
The modified Miller Score (MMS) is a score of thrombus load proposed by Miller et al 
[12] for conventional angiography and adapted for CTPA scan by Bankier et al [13].  
Each segmental pulmonary artery (nine on the right, seven on the left) that is fully or 
partly occluded by thrombus is given a score of 1. Any more proximal involved vessels 
scores the number of segmental branches distal to that vessel thereby giving a MMS of 0 
(no thrombus) to 16 (thrombus in all segmental arteries or saddle embolism). The 
modified Miller Score was evaluated in consensus between observers.  
The right ventricular to left ventricular ratio was calculated using the minor axes of the 
RV and LV chambers in the axial plane at the widest points between the inner surface of 
the free wall and the surface of the interventricular septum.  The maximum dimensions of 
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the right ventricle and left ventricles may be found at different axial scan levels. This is 
illustrated in Figure 1. 
The presence of septal shift, maximum pulmonary artery and ascending aortic diameter 
were also recorded. Finally, the presence or absence of consolidation, atelectasis or an 
effusion was recorded.   
  
 
Figure 1:  Illustration of measurement of maximum minor axis dimensions in a 
patient with right ventricular strain and septal shift. RV = right ventricle 
measurement. LV= left ventricular measurement 
 
Statistical methods 
All data were analysed using SPSS V.13 for windows (SPSS INC., Chicago, IL). Data are 
presented as mean (standard deviation) unless otherwise stated. Non-parametric analysis 
was undertaken using Independent samples two-tailed test or chi-squared. Correlations 
were calculated using Pearson rank correlation. A significance value of p≤ 0.05 was 
applied. Inter-observer reproducibility between the two observers for the RV: LV ratio 
was assessed on 25 scans using Bland-Altman analysis [16].  




Figure 2 a 
 
Figure 2b 
 (a) Large central embolus (arrows) with Modified Miller Score (MMS) 16. 
(b) RV dilatation, septal straightening (arrow) and increase in RV: LV ratio 











During the 40 month period 559 CTPA scans were reported as positive for pulmonary 
embolism (PE); of these 55 were excluded for reasons including change in diagnosis on 
review or technically suboptimal scans for the accurate calculation of MMS.  A final total 
of 504 scans where included in the study. For the negative PE group, the results of 100 
consecutive scans within an equivalent cohort during the study period were included. 
 
For the patients with PE, the MMS ranged from 1-16, with a mean MMS of 7.86. The 
mean RV: LV ratio was 1.087 (SD 0.412) and median 0.9794 (range 0.52-3.29). This 
along with the presence of consolidation, atelectasis and pleural effusion is demonstrated 
in Table 1. In the entire cohort, increasing MMS was shown to correlate with a higher 
RV: LV ratio (Pearson rank co-efficient r=0.390, p<0.001) and with pulmonary artery 
diameter (Pearson rank co-efficient r=0.221, p<0.001). Positive CTPA scan with 
increased RV: LV ratio is illustrated in Figure 2 (a and b). 
 
The mean RV: LV ratio remained unchanged until a thrombus load of MMS of ≥ 12 was 
reached.  For patients with lower thrombus loads (MMS ≤ 12, n=338,) there was no 
significant differences for RV: LV ratio when comparing to the no PE cohort (mean RV: 
LV ratio 0.971 (SD 0.242) Vs 0.930 (SD 0.133), p=0.108) but there was a significant 
difference in mean ratio for higher thrombus loads (MMS ≥ 12, n=166) when compared to 
the no-PE cohort (mean RV: LV ratio 1.323 (SD 0.561) Vs 0.930 (SD 0.133), p<0.0001). 
Multiple analyses were carried out comparing each MMS from 1 - 12 and demonstrated 
there was no statistical significance between any two mean MMS scores in this cohort 
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(independent samples t-test, all p>0.05 for all comparison). The correlation coefficients 
were calculated for MMS 1-12, which demonstrated no significant correlation (Pearson 
rank correlation = 0.0526, p=0.315). For larger thrombus loads of MMS ≥ 12, however, 
there was a significant correlation between MMS and RV: LV ratio (Pearson rank co-
efficient r=0.232, p=0.003). This association did not hold true for either pulmonary artery 
diameter or aortic diameter (non-significant for MMS <12 and MMS ≥ 12 groups).  This 
is demonstrated in Table 2 and in graphical form in Figure 3.  
 
Figure 3: Graph of data showing the relationship of mean RV: LV ratio with Modified 
Miller Score with the RV: LV ratio remaining stable until MMS ≥ 12 with statistically 
significant higher mean ratio for higher thrombus loads (MMS ≥12) compared with non-
PE cohort (p <0.0001).  
 
Septal changes (defined as septal straightening or septal bulge into the left ventricle) were 
also more likely with MMS of ≥ 12 than MMS ≤ 12 (63.8% Vs 18.6% P<0.001). 
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In terms of interobserver agreement, on Bland-Altman analysis of the RV: LV ratio 
measurements, the means and SDs between the two observers were 0.04 and 0.22 
respectively. The Bland-Altman plot is shown in Figure 4. 
 
Figure 4: Bland-Altman plot of the RV: LV ratio as measured by the two study 




We believe this to be the first study to describe the relationship between thrombus load 
and RV: LV ratio on CTPA examinations. The RV: LV ratio remains relatively 
unchanged until MMS score ≥ 12. Above this thrombus load, the right ventricle begins to 
dilate in keeping with decompensation indicating a ‘tipping point’. ‘Tipping point’ is a 
concept used in physics and sociology and is defined as the critical point in an evolving 
situation that leads to a new and potentially irreversible development [17].  
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Our results show that not all patients with a high thrombus load have evidence of RV 
decompensation. This implies that some patients with high thrombus loads are able to 
compensate while others do not, resulting in the right ventricular strain and dilatation 
visible on CTPA. This is evidenced by the large standard deviations seen in the Figure 3 
for MMS 12, MMS 13 and MMS 15. The mechanism for this disparity remains unclear 
and could possibly be due to a number of factors. One suggestion is that those patients 
without RV dilatation are decompressing their right ventricular afterload through 
temporary right to left cardiac shunts [18]. Autopsy studies have shown prevalence of 
patent foramen ovale in the general population of up to 27% [19], whilst 
echocardiography in both transthoracic and transoesophageal studies has shown incidence 
of patent foramen ovale (PFO) in the healthy population of 10- 24.3%[20-22].  An 
unsuspected PFO may open up and allow temporary right to left shunting in the presence 
of raised right heart pressure, which may reduce the acute right ventricular dilatation on 
CT. This however is unlikely to equate to a survival benefit: it has previously been shown 
that those who have a PFO in the setting of PE have an overall mortality of 33% versus 
14% in the absence of a PFO, likely to be due to paradoxical embolus and secondary 
myocardial ischaemia [23]. Another possibility is that patients capable of RV 
compensation may have a better protected RV myocardium because they do not have pre-
existing sub-clinical coronary disease. It is recognised that patients may develop RV 
ischaemia or infarction as a result of significant increase in RV afterload when PE occurs 
[24].  Animal studies have also previously shown that right ventricular muscle can 
hypertrophy fairly rapidly over the course of a couple of weeks in response to increased 
RV pressure [25]. This could provide a further explanation for why some patients may 
have increased their right ventricular muscle bulk in response to repeated silent earlier 
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pulmonary emboli enabling them to avoid right ventricular collapse in the presence of 
larger thrombus loads. 
 
There are also a small number of outliers in whom there is a raised RV: LV ratio, but with 
relatively low thrombus loads reflecting the heterogeneous population in whom PE is 
diagnosed. 
 
We acknowledge that criticism may arise from the choice of study protocol utilised. We 
chose to utilise MMS and non-cardiac gating as well as axial RV: LV ratios as these were 
more representative of daily radiology practice than using more complicated thrombus 
load scores such as the Walsh, Qanaldi or Mastora scores and volumetric RV: LV 
measurements. Whilst we acknowledge volumetric analysis of RV volume: LV volume 
has been shown to be the most reproducible measurement [26] and slightly superior in 
identifying high risk patients with adverse clinical outcomes than uni-dimensional 
measurements, it is time consuming and requires dedicated software tools which would be 
disadvantageous in the emergency setting [27].  With non cardiac-gated scans whilst there 
was a degree of cardiac motion artefact, this did not adversely affect the ventricular wall 
detection and measurement in diastole. As reported previously by investigators from our 
institution [10], the patients in the major PE group also exhibited reduced cardiac motion 
artefact compared to the non-PE group, which is likely to reflect ventricular dyskinesis 
associated with major PE [28], which allows reproducible measurements as demonstrated 
by the high inter-observer agreement between the two observers in out study (Bland-
Altman analysis, mean 0.04 and SDs 0.22). We acknowledge the limitations of scanner 
protocol however any inaccuracies in axial measurements would however not be expected 
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to alter the correlation we have shown between clot burden and the degree of RV 
dilatation.  
 
This study was designed as purely radiological study and consequently we have not 
included clinical outcomes of these patients. Studies have consistently demonstrated a 
poorer prognosis associated with right heart strain [5,6] and data from a number of studies 
have now confirmed an increased risk of mortality in patients who have evidence of right 
heart strain, either through biomarkers of cardiac injury through Troponin or BNP [29-
32], or radiological and echocardiogram evidence of right heart strain [5, 6, 30]. In this 
cohort of patients without circulatory collapse, it is still not known whether treatment with 
thrombolysis is warranted as a recent study [33], currently in press, has noted that whilst 
pulmonary artery obstruction scores can differentiate between patients with and without 
RV dysfunction, these were not correlated to adverse clinical outcome. Using only RV: 
LV ratio or thrombus load measurements in clinical decision making may be misleading 
as a significant number of patients with either no-PE, or with lower thrombus loads may 
also have an increased RV: LV ratio. Further work is in progress to correlate this ‘tipping 
point’ between thrombus load and right heart strain with eventual clinical outcome in 
order to help improve the existing treatment algorithms in pulmonary thromboembolism.  
 
Conclusion 
Using CT pulmonary angiography, we have demonstrated that in acute pulmonary 
thromboembolism, the RV: LV ratio remains relatively unchanged with increasing 
thrombus load until the ‘tipping point’ of MMS of 12 above which right ventricular 
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dilatation is more likely to occur. Although further larger studies are required to correlate 
with clinical outcomes, these findings may contribute to the process of risk stratification 
for this patient group and affect treatment such as decision for use of fibrinolytic therapy.  
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The papers included in this thesis were published over a period of nearly ten years. This 
has been a time of immense change in the radiological assessment of VTE and also a time 
which has seen growth in our understanding of the disease. It has been illuminating 
looking back through these various papers and reflecting on what has been learnt and also 
what might, in hind-sight, have been done differently in approach to these same issues, 
knowing what we know now, were we to have our time over again. In this final section 
the main points of each chapter will be summarised and where lessons have been learnt 
that might have been applied they will be raised.  
The first chapter is a short historical overview is given highlighting the pivotal role of 
imaging in the diagnosis and understanding of venous thromboembolism. The background 
to the thesis is explained and the future of VTE and radiological assessment of the disease 
is explored. 
Chapter II looked at the changing practice for investigation of suspected pulmonary 
embolism shortly after the introduction of CT pulmonary angiography (CTPA).  The 
algorithms for investigation employed, although agreed best practice at the time, now look 
sadly dated and radiologists and clinicians who did not work through that era will, I am 
sure, find them somewhat obscure and maybe even perplexing. CTPA, especially with the 
accuracy in diagnosis afforded by Multi-slice CT scanning, is now largely a’ one-stop 
shop’. Even in the early days it was clear as shown by this paper that radiology would be 
the victim of its own success. It was shown that with the introduction of CTPA that the 
total number of investigation rose steadily and that the number of non-diagnostic studies 
decreased  This increase in investigations has continued apace. We are in the process of 
reviewing the imaging for suspected PE for 2011-12 and have shown the rate of 
investigation for suspected acute PE has risen over  250% compared to a decade earlier. . 
Insights into VTE                                        John T Murchison                                                      
 
 179 
The positive scan rate dropped slightly in this recent study to but the actual incidence 
of acute PE more than doubled over 10 years. The increased incidence of diagnosed PE 
maypartly be due to a chaging in patient demographics and a genuine increase in 
incidence but is likely to primarily reflect  more efficient detection of less severe disease. 
If this is the case, then aggressive treatment may not be appropriate in all cases and further 
analysis of outcomes, based on a PE severity score, should be considered. Further analysis 
is required to see if there is a change in PE severity, and to assess patient outcomes, such 
as recurrent thromboembolism in patients receiving treatment and those with negative 
scans. 
 
Chapter III looked at the change in patient dose resulting from the change in practice. It 
was shown that with the increased number of patients investigated, that the total patient 
dose rose. However the average patient dose did not appear to change significantly as 
there were less supplementary tests after non-diagnostic studies resulting in less 
radiological investigations per patient. Looking back at this paper, the most striking thing 
is that the CTPA dose, although calculated by medical physics, appears rather lower than I 
would have expected when you consider the doses calculated for current CT scanners. 
There may be various reasons for this. One reason is that the conversion factor for 
determining dose has been adjusted in the light of new understanding resulting in higher 
per study calculated milli-sievert levels. Another reason is that this study, carried out as it 
was in the early days of CTPA was performed on a single slice CT scanner. For a CTPA it 
is imperative that the scan  is performed during a single breath-hold and to achieve this 
with a single slice scanner only the middle portion of the chest from aortic arch to tip of 
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diaphragm was covered, using a high pitch. Both the high pitch and the limited volume 
included would result in a lower radiation dose. Doses with modern multi-slice CT 
scanner vary a lot. The routine nowadays would be to cover the whole chest, to benefit 
from the extra information provided. That, along with the great increase in slices acquired 
result in increased radiation. Consequently I expect current doses are considerably higher 
than those quoted in this paper. That said, great efforts are being made to reduce radiation 
levels, with development of better detectors and iterative reconstruction and it is very 
likely that doses will drop significantly.  Because of the patient safely issue radiation dose 
is an important issue leaving a lot of scope for further research and evaluation in this field.  
Chapter IV looks in depth at a cohort of patients presenting with clinically suspected PE 
and showed that clinical characteristics, co-morbidities and radiological features were 
similar when comparing groups with CTPA-proven or CTPA refuted PE. RV dimensions, 
radiological consolidation on imaging and D-dimer levels were however significantly 
higher in the PE group. In this outcome study a particularly interesting finding, is that that 
the cohort of patients investigated for suspected PE have a poorer prognosis, compared 
with age matched controls, irrespective of whether PE is confirmed. This appears 
accentuated in patients without PE, a finding which merits wider recognition and further 
evaluation. 
In Chapter V the results of SimliRED a simple beside D-dimer assay are prospectively 
blindly compared with CTPA results.  This study was carried out in the early  days of D-
Dimer testing, and what was not particularly appreciated at that time and I suspect still not 
appreciated by all, is that not all D-Dimer tests are the same.  Simple yes/no assays such 
as SimpliRED are much inferior to ELISA D-Dimer assays and a negative SimpliRED D-
Insights into VTE                                        John T Murchison                                                      
 
 181 
dimer assay in isolation does not safely exclude the diagnosis of a pulmonary embolism. 
We had naively thought that a simple bed-side D-Dimer test on its own might be adequate 
to rule out PE and to triage patients appropriate for CTPA. Looking back, were I to do this 
study again, I would have included clinical probability scoring along with D-dimer 
testing. This is particularly  imperative when bed-side assays D-dimer test are assessed. 
In Chapter VI consecutive enhanced in-patient and in Chapter VII consecutive 
enhanced outpatient non-CTPA chest CT scans, were reviewed to look for unsuspected 
PEs. These were among the first papers published which looked at large cohorts of 
unselected patients in this manner and in both a significant number of unsuspected 
pulmonary emboli were identified. These PEs were generally smaller than PEs identified 
at CTPA and were more commonly seen in elderly patients. Only about two thirds of 
these PEs had been reported on the initial scan. The main lesson was that PEs should be 
routinely sought in all contrast enhanced CTs of the chest irrespective of the indication for 
the scan, a lesson resulting in change of radiological practice, following  publication of 
these papers. Looking back, the one thing in particular that I would do different if 
repeating these studies would be to record the Hounsfield Attenuation of the pulmonary 
arteries to measure enhancement of the main pulmonary artery rather than using the 
subjective assessment enhancement that was employed. Quantitative measures are better 
science than objective measures and CT enhancement lends itself to this. It also improves 
reproducibility.  
Chapter VIII used a VTE database to look at distribution of DVT as demonstrated by 
contrast venography. It was shown that almost a third of positive cases were isolated, 
below knee thrombi. The importance of this is that these smaller thrombi are more 
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difficult to detect by non-invasive means such as ultrasound which is now almost 
universally employed to identify DVT. Our study laid down a reference for relative 
distribution of below and above knee DVT from pre-US days which can be used as a 
standard to determine approximately how many below knee DVT are being missed in a 
given US DVT series. The reviewers of this paper suggested following up these two 
cohorts of above and below knee DVT to look at incidence of recurrent VTE and 
development of chronic venous insufficiency. This has been done with interesting results 
which we plan to publish shortly.  
Chapters IX, X and XI are a Trilogy of papers using the SHIPs database to conduct 
nationwide, retrospective cohort studies The first assessed the risk of cancer developing in 
VTE patients diagnosed in Scotland over an eighteen year period and showed 
significantly elevated risks of cancer which were sustained for two years after VTE 
diagnosis; most notably for ovarian tumours and lymphomas.  Younger patients had a 
lower overall, but increased relative, risk of this association. The second of these papers 
linked cases of DVT with metrological variables.  The main findings were that low 
atmospheric pressure, high rainfall and high wind speed are associated with a small but 
significant increase in the rate of DVT. The correlation is strong, but the cynic might 
argue that it is simply down to sitting around and immobility resulting from adverse 
weather. However I am convinced that the association is real and consider this association 
of DVT with a reduction in atmospheric pressure the most interesting finding in this 
paper. It may account in part for ‘economy class syndrome’ in long haul flights, in which 
a reduction in cabin pressure occurs possibly mimicking this climatic change. In my 
opinion this merits further evaluation, my expectation being that this effect may not be 
universal, occurring only in susceptible individuals. The lag between insult and 
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presentation is also of interest illustrating the time interval it often takes from initial early 
clot formation to clinical presentation. This time is not fixed but peaks around 9-11 days. 
Given that PE generally occurs after a DVT it might be expected that the time from initial 
insult to clinical presentation of PE might be longer and even more variable.  
In Chapter XI, the third of the SHIPs based papers, it was shown that the prognosis was 
significantly poorer in patients in whom VTE occurred up to two years before the 
diagnosis of a new cancer diagnosis. This association was most notable if cancer was 
diagnosed in the six months after a VTE. The question which this paper raises is whether 
this poor outcome is simple due to these patients having more severe disease or whether 
the presence of preceding DVT is identifying a phenotype of more aggressive malignancy 
with a poorer outcome. If the answer is the former then it might be argued that these 
patients should be investigated more thoroughly, if the latter then it may be that extensive 
investigation for underlying malignancy may not yield a survival benefit in these patients. 
It would have been useful to have been able to include staging information for these 
patients to help clarify this point. Unfortunately this was not available at the time of this 
paper, however it is now available for linkage and would make a valuable follow up study 
to clarify the situation.  The data presented in Chapters IX and XI may also be useful for 
health economists and epidemiologists to calculate the cost effectiveness of screening 
VTE patients for underlying malignancy   
Chapter XII assessed the correlation between increasing pulmonary embolism thrombus 
load and right ventricular dilatation as demonstrated by CTPA and assessed the thrombus 
load threshold which indicates impending right ventricular decompensation. It was shown 
that in acute pulmonary thromboembolism, the RV: LV ratio remains relatively 
unchanged with increasing thrombus load until the ‘tipping point’ of MMS of 12 above 
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which right ventricular dilatation is more likely to occur. It was concluded that these 
findings may contribute to the process of risk stratification for this patient group and 
affect treatment such as decision for use of fibrinolytic therapy. In this paper we 
developed our understanding of the relationship between thrombus load and right 
ventricular strain. In chapter IV a similar but smaller group of patients had been examined 
and in that paper a quadratic curve was applied to the scatter plot. The ‘tipping point’ 
hypothesis presented in chapter XII better explains the findings and complies with what 
might be expected physiologically in light of Starling’s Law of myocardial contractility.  
In conclusion, deep venous thrombosis and pulmonary embolism are part of the same 
disease spectrum of venous thrombo-embolism. VTE is a common disease whose 
presentation mirrors many other pathologies and the diagnosis cannot be made with any 
confidence without imaging input. It is a much feared disease which is still poorly 
understood but whose understanding has been improved with the help of imaging and of 
clinical databases. By using imaging derived data and data from both local and national 
databases the understanding of various aspects of this common, but still relatively poorly 
understood, disease process have been evaluated and advanced. The work has laid the 
foundation for further investigation in the field some of which is already underway with 














The focus of this project is venous thromboembolism, a topic which I first caught my 
interest as a radiology trainee at Edinburgh Royal Infirmary. That interest was generated 
by the enthusiasm that John Reid, who was a consultant radiologist in the department at 
that time, had for the topic. John was instrumental in setting up a database of patients 
transiting the department with suspected venous thrombo-embolism and I was fortunate to 
be invited by him to assist with that database which formed the basis of my earliest 
venous thrombo-embolism publications. John Reid not only first introduced me to the 
vast ongoing potential for VTE research but has over the years been inspirational in 
focussing many of the VTE based studies in which I have been involved. John has been, 
and continues to be, an invaluable collaborator in many of my paper on venous 
thromboembolism with further collaborative VTE projects at various stages of completion 
and my greatest thanks in this field are due to him.  
Databases are an invaluable tool when it comes to quantifying and evaluating disease. As 
well as our radiology VTE database I have also made use of the Scottish Hospital and In-
Patients Statistics (SHIPS)  database for several of these publications. This is a resource 
which I first encountered as a medical Senior House Officer at the Gastro-Intestinal Unit 
at the Western General Hospital Edinburgh whilst carrying out a research project under 
the supervision of Professor Anne Ferguson for whose help I am very grateful. The 
remit of that post also included attending courses on epidemiology and statistics, 
disciplines which have proved useful for publications included for this PHD. Several 
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papers started off as student Special Study Module projects and my thanks are due to 
students who participated in data collection and initial analysis for these projects 
including Gordon Cowell, Lynne Wylie, Asam Akram, and Louise Logan.  It has been 
encouraging to see how some of those who have chosen radiology SSM projects as 
students have gone on to pursue a career in radiology.  
Research is seldom purely radiological and often multidisciplinary. I am grateful for the 
clinical support given for some of these publications. I wish to thank Professor Derek 
Bell for his help with the Simpli-RED D-dimer  CTPA study and  Professor John 
Simpson who was an enthusiastic and perceptive collaborator in several of the PE 
projects before moving to take up his chair in Newcastle.  I am also greatly indebted to 
Professor Bill McNee and to Nik Hirani, for the opportunities they have afforded me to 
collaborate in respiratory research in their specialist fields when a radiology perspective 
has been required.  It was a very welcome boost to have Professor Edwin van Beek 
come to Edinburgh to take up the SINAPSE Chair of Radiology. Edwin, particularly in 
his role as supervisor, has   been very supportive of this project and, the phone calls, 
letters and e-mails which he wrote to chivvy things along, the support he has provided, 
and his advice in the preparation of this manuscript, are much appreciated. 
I am fortunate in having the assistance of numerous registrars and SpRs in training that 
have willingly assisted with various aspects of these papers. These include, Catriona 
Farrell, Mark Jones, Francis Girvin, Gillian Ritchie, Simon McGurk, Catriona 
McCreath, Deepak Subedi, Marina Brochwitz-Lewinski, and John O'Neill. It is great 
now to have them as consultant colleagues both around the UK and also in North 
America. 
